CN107106437B - 用于减少毛发卷曲的组合物 - Google Patents
用于减少毛发卷曲的组合物 Download PDFInfo
- Publication number
- CN107106437B CN107106437B CN201580066199.0A CN201580066199A CN107106437B CN 107106437 B CN107106437 B CN 107106437B CN 201580066199 A CN201580066199 A CN 201580066199A CN 107106437 B CN107106437 B CN 107106437B
- Authority
- CN
- China
- Prior art keywords
- rinse
- conditioner composition
- hair
- composition according
- moisture control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 202
- 239000000463 material Substances 0.000 claims abstract description 98
- 230000009467 reduction Effects 0.000 claims abstract description 41
- -1 methoxy, ethoxy, hydroxy Chemical group 0.000 claims abstract description 37
- 239000006254 rheological additive Substances 0.000 claims description 30
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 28
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 27
- 150000001875 compounds Chemical class 0.000 claims description 25
- 239000003093 cationic surfactant Substances 0.000 claims description 22
- 208000001840 Dandruff Diseases 0.000 claims description 19
- 230000003750 conditioning effect Effects 0.000 claims description 19
- 238000002844 melting Methods 0.000 claims description 16
- 230000008018 melting Effects 0.000 claims description 16
- NKBASRXWGAGQDP-UHFFFAOYSA-N 5-chlorosalicylic acid Chemical compound OC(=O)C1=CC(Cl)=CC=C1O NKBASRXWGAGQDP-UHFFFAOYSA-N 0.000 claims description 14
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 14
- 229960004889 salicylic acid Drugs 0.000 claims description 14
- 239000000375 suspending agent Substances 0.000 claims description 13
- 239000008365 aqueous carrier Substances 0.000 claims description 11
- 229920001296 polysiloxane Polymers 0.000 claims description 11
- UIAFKZKHHVMJGS-UHFFFAOYSA-N 2,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1O UIAFKZKHHVMJGS-UHFFFAOYSA-N 0.000 claims description 10
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 claims description 5
- 229940114055 beta-resorcylic acid Drugs 0.000 claims description 5
- 239000004599 antimicrobial Substances 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 150000002009 diols Chemical class 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 239000013543 active substance Substances 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 239000002738 chelating agent Substances 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 230000003646 hair health Effects 0.000 claims description 2
- 239000000049 pigment Substances 0.000 claims description 2
- 229920000151 polyglycol Polymers 0.000 claims description 2
- 239000010695 polyglycol Substances 0.000 claims description 2
- 239000003082 abrasive agent Substances 0.000 claims 1
- 230000000975 bioactive effect Effects 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- 239000003002 pH adjusting agent Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 56
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 23
- 239000001257 hydrogen Substances 0.000 abstract description 23
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 abstract description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract description 9
- 108090000623 proteins and genes Proteins 0.000 abstract description 9
- 102000004169 proteins and genes Human genes 0.000 abstract description 9
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract description 6
- 230000002378 acidificating effect Effects 0.000 abstract description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract description 6
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 5
- 229910052736 halogen Inorganic materials 0.000 abstract description 5
- 150000002367 halogens Chemical class 0.000 abstract description 5
- 150000002431 hydrogen Chemical class 0.000 abstract description 5
- 229910021645 metal ion Chemical group 0.000 abstract description 5
- 238000005192 partition Methods 0.000 abstract description 5
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 abstract description 5
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract description 5
- 229920002554 vinyl polymer Polymers 0.000 abstract description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 abstract description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 43
- 125000000217 alkyl group Chemical group 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 150000003863 ammonium salts Chemical class 0.000 description 21
- 229920001577 copolymer Polymers 0.000 description 20
- 230000008901 benefit Effects 0.000 description 19
- 238000011282 treatment Methods 0.000 description 18
- 230000000670 limiting effect Effects 0.000 description 17
- 239000003795 chemical substances by application Substances 0.000 description 15
- 150000003839 salts Chemical class 0.000 description 15
- 229920000642 polymer Polymers 0.000 description 13
- 239000011701 zinc Substances 0.000 description 13
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 12
- 229940048053 acrylate Drugs 0.000 description 12
- YBBJKCMMCRQZMA-UHFFFAOYSA-N pyrithione Chemical class ON1C=CC=CC1=S YBBJKCMMCRQZMA-UHFFFAOYSA-N 0.000 description 12
- 229910052725 zinc Inorganic materials 0.000 description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 11
- 150000002191 fatty alcohols Chemical class 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 10
- 230000035515 penetration Effects 0.000 description 10
- 239000002453 shampoo Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 150000001298 alcohols Chemical class 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 229960002026 pyrithione Drugs 0.000 description 9
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- 230000000845 anti-microbial effect Effects 0.000 description 8
- 125000003118 aryl group Chemical group 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 8
- 239000000178 monomer Substances 0.000 description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 8
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 229920002125 Sokalan® Polymers 0.000 description 7
- 125000003545 alkoxy group Chemical group 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 229940060384 isostearyl isostearate Drugs 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 210000004761 scalp Anatomy 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- XULHFMYCBKQGEE-MRXNPFEDSA-N 2-Hexyl-1-decanol Natural products CCCCCCCC[C@H](CO)CCCCCC XULHFMYCBKQGEE-MRXNPFEDSA-N 0.000 description 6
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 6
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 125000002877 alkyl aryl group Chemical group 0.000 description 6
- 229920006317 cationic polymer Polymers 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 229920000058 polyacrylate Polymers 0.000 description 6
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 5
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 5
- 239000013531 ACULYN rheology modifier Substances 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 235000010980 cellulose Nutrition 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920006037 cross link polymer Polymers 0.000 description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 5
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 5
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 229960004125 ketoconazole Drugs 0.000 description 5
- 229950001046 piroctone Drugs 0.000 description 5
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000003760 tallow Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 244000303965 Cyamopsis psoralioides Species 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 4
- HPEUJPJOZXNMSJ-UHFFFAOYSA-N Methyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC HPEUJPJOZXNMSJ-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- 125000005233 alkylalcohol group Chemical group 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 230000003699 hair surface Effects 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- LYRFLYHAGKPMFH-UHFFFAOYSA-N octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(N)=O LYRFLYHAGKPMFH-UHFFFAOYSA-N 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 4
- 229940043810 zinc pyrithione Drugs 0.000 description 4
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 4
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 3
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010019049 Hair texture abnormal Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- 125000005250 alkyl acrylate group Chemical group 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 229920013822 aminosilicone Polymers 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 150000001733 carboxylic acid esters Chemical class 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 229960003344 climbazole Drugs 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 229960002989 glutamic acid Drugs 0.000 description 3
- 150000002314 glycerols Chemical class 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000000149 penetrating effect Effects 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 229920001515 polyalkylene glycol Polymers 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- VIDTVPHHDGRGAF-UHFFFAOYSA-N selenium sulfide Chemical compound [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 3
- 229960005265 selenium sulfide Drugs 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- FMZUHGYZWYNSOA-VVBFYGJXSA-N (1r)-1-[(4r,4ar,8as)-2,6-diphenyl-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-4-yl]ethane-1,2-diol Chemical group C([C@@H]1OC(O[C@@H]([C@@H]1O1)[C@H](O)CO)C=2C=CC=CC=2)OC1C1=CC=CC=C1 FMZUHGYZWYNSOA-VVBFYGJXSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 description 2
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 2
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 description 2
- AKEUNCKRJATALU-UHFFFAOYSA-N 2,6-dihydroxybenzoic acid Chemical compound OC(=O)C1=C(O)C=CC=C1O AKEUNCKRJATALU-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 2
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 2
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- FEPBITJSIHRMRT-UHFFFAOYSA-N 4-hydroxybenzenesulfonic acid Chemical compound OC1=CC=C(S(O)(=O)=O)C=C1 FEPBITJSIHRMRT-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 235000017788 Cydonia oblonga Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- 241000357437 Mola Species 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 description 2
- 229920002367 Polyisobutene Polymers 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 description 2
- DTHZWUDUWBPDQI-UHFFFAOYSA-N [Zn].ClO Chemical compound [Zn].ClO DTHZWUDUWBPDQI-UHFFFAOYSA-N 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 150000008052 alkyl sulfonates Chemical class 0.000 description 2
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000003851 azoles Chemical class 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011280 coal tar Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- SUCKQWWOYOOODR-UHFFFAOYSA-K copper;zinc;carbonate;hydroxide Chemical compound [OH-].[Cu+2].[Zn+2].[O-]C([O-])=O SUCKQWWOYOOODR-UHFFFAOYSA-K 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- 238000002788 crimping Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229940087101 dibenzylidene sorbitol Drugs 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- 229960003913 econazole Drugs 0.000 description 2
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- CAMHHLOGFDZBBG-UHFFFAOYSA-N epoxidized methyl oleate Natural products CCCCCCCCC1OC1CCCCCCCC(=O)OC CAMHHLOGFDZBBG-UHFFFAOYSA-N 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- VFPFQHQNJCMNBZ-UHFFFAOYSA-N ethyl gallate Chemical compound CCOC(=O)C1=CC(O)=C(O)C(O)=C1 VFPFQHQNJCMNBZ-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 229920013819 hydroxyethyl ethylcellulose Polymers 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical group [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 description 2
- 229960004130 itraconazole Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 2
- QSQLTHHMFHEFIY-UHFFFAOYSA-N methyl behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OC QSQLTHHMFHEFIY-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- UQDUPQYQJKYHQI-UHFFFAOYSA-N methyl laurate Chemical compound CCCCCCCCCCCC(=O)OC UQDUPQYQJKYHQI-UHFFFAOYSA-N 0.000 description 2
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 description 2
- 229940073769 methyl oleate Drugs 0.000 description 2
- ZAZKJZBWRNNLDS-UHFFFAOYSA-N methyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC ZAZKJZBWRNNLDS-UHFFFAOYSA-N 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 229960003921 octisalate Drugs 0.000 description 2
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 229940037312 stearamide Drugs 0.000 description 2
- 229940100459 steareth-20 Drugs 0.000 description 2
- 229940073743 steareth-20 methacrylate Drugs 0.000 description 2
- 229940012831 stearyl alcohol Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000011269 treatment regimen Methods 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- BLSQLHNBWJLIBQ-OZXSUGGESA-N (2R,4S)-terconazole Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2N=CN=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 BLSQLHNBWJLIBQ-OZXSUGGESA-N 0.000 description 1
- RPAJSBKBKSSMLJ-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCC(O)=O RPAJSBKBKSSMLJ-DFWYDOINSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- MPIPASJGOJYODL-SFHVURJKSA-N (R)-isoconazole Chemical compound ClC1=CC(Cl)=CC=C1[C@@H](OCC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 MPIPASJGOJYODL-SFHVURJKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- VUWCWMOCWKCZTA-UHFFFAOYSA-N 1,2-thiazol-4-one Chemical class O=C1CSN=C1 VUWCWMOCWKCZTA-UHFFFAOYSA-N 0.000 description 1
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 1
- ZCJYUTQZBAIHBS-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)benzyl]oxy}ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=1C=CC(SC=2C=CC=CC=2)=CC=1)CN1C=NC=C1 ZCJYUTQZBAIHBS-UHFFFAOYSA-N 0.000 description 1
- HAAITRDZHUANGT-UHFFFAOYSA-N 1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1C(OCC=1C2=CC=CC(Cl)=C2SC=1)CN1C=NC=C1 HAAITRDZHUANGT-UHFFFAOYSA-N 0.000 description 1
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 description 1
- GHJOEPMHSNXADF-UHFFFAOYSA-N 1-aminoicosan-2-ol Chemical compound CCCCCCCCCCCCCCCCCCC(O)CN GHJOEPMHSNXADF-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- QXHHHPZILQDDPS-UHFFFAOYSA-N 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound S1C=CC(COC(CN2C=NC=C2)C=2C(=CC(Cl)=CC=2)Cl)=C1Cl QXHHHPZILQDDPS-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical class OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 1
- 229940082044 2,3-dihydroxybenzoic acid Drugs 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- MQFYRUGXOJAUQK-UHFFFAOYSA-N 2-[2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC MQFYRUGXOJAUQK-UHFFFAOYSA-N 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- NDLNTMNRNCENRZ-UHFFFAOYSA-N 2-[2-hydroxyethyl(octadecyl)amino]ethanol Chemical compound CCCCCCCCCCCCCCCCCCN(CCO)CCO NDLNTMNRNCENRZ-UHFFFAOYSA-N 0.000 description 1
- MBRHNTMUYWQHMR-UHFFFAOYSA-N 2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one Chemical class NCCO.ON1C(=O)C=C(C)C=C1C1CCCCC1 MBRHNTMUYWQHMR-UHFFFAOYSA-N 0.000 description 1
- CYMRPDYINXWJFU-UHFFFAOYSA-N 2-carbamoylbenzoic acid Chemical compound NC(=O)C1=CC=CC=C1C(O)=O CYMRPDYINXWJFU-UHFFFAOYSA-N 0.000 description 1
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- XVZIAZAFOVOYAT-TTWKNDKESA-N 2-methyloxirane;(e)-octadec-9-enoic acid;oxirane Chemical compound C1CO1.CC1CO1.CCCCCCCC\C=C\CCCCCCCC(O)=O XVZIAZAFOVOYAT-TTWKNDKESA-N 0.000 description 1
- KOZZOZYINRDZOU-UHFFFAOYSA-N 2-octadecoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KOZZOZYINRDZOU-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- AJHPGXZOIAYYDW-UHFFFAOYSA-N 3-(2-cyanophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)NC(C(O)=O)CC1=CC=CC=C1C#N AJHPGXZOIAYYDW-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- KSLINXQJWRKPET-UHFFFAOYSA-N 3-ethenyloxepan-2-one Chemical compound C=CC1CCCCOC1=O KSLINXQJWRKPET-UHFFFAOYSA-N 0.000 description 1
- AVQZTOVGAJLQFB-UHFFFAOYSA-N 3-hexyldecan-1-ol Chemical compound CCCCCCCC(CCO)CCCCCC AVQZTOVGAJLQFB-UHFFFAOYSA-N 0.000 description 1
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 1
- IICCLYANAQEHCI-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 IICCLYANAQEHCI-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- KYSYWQIRMYSEEY-UHFFFAOYSA-N C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)C(O)CN Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)C(O)CN KYSYWQIRMYSEEY-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 244000236931 Cydonia oblonga Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000004262 Ethyl gallate Substances 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- CTETYYAZBPJBHE-UHFFFAOYSA-N Haloprogin Chemical compound ClC1=CC(Cl)=C(OCC#CI)C=C1Cl CTETYYAZBPJBHE-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000764238 Isis Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- ZRTQSJFIDWNVJW-WYMLVPIESA-N Lanoconazole Chemical compound ClC1=CC=CC=C1C(CS\1)SC/1=C(\C#N)N1C=NC=C1 ZRTQSJFIDWNVJW-WYMLVPIESA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229920003188 Nylon 3 Polymers 0.000 description 1
- MTUBBMSQXXJFQP-UHFFFAOYSA-N OC(CCCCCCCCCCCCCCCCC(=O)OCC(O)CO)(O)O Chemical compound OC(CCCCCCCCCCCCCCCCC(=O)OCC(O)CO)(O)O MTUBBMSQXXJFQP-UHFFFAOYSA-N 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CRKGMGQUHDNAPB-UHFFFAOYSA-N Sulconazole nitrate Chemical compound O[N+]([O-])=O.C1=CC(Cl)=CC=C1CSC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 CRKGMGQUHDNAPB-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- OCKWAZCWKSMKNC-UHFFFAOYSA-N [3-octadecanoyloxy-2,2-bis(octadecanoyloxymethyl)propyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC OCKWAZCWKSMKNC-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000007824 aliphatic compounds Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940063656 aluminum chloride Drugs 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 229940110830 beheneth-25 methacrylate Drugs 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 229960002206 bifonazole Drugs 0.000 description 1
- 238000000861 blow drying Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960002120 butoconazole nitrate Drugs 0.000 description 1
- ZHPWRQIPPNZNML-UHFFFAOYSA-N butoconazole nitrate Chemical compound O[N+]([O-])=O.C1=CC(Cl)=CC=C1CCC(SC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 ZHPWRQIPPNZNML-UHFFFAOYSA-N 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Chemical class OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical class CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- 229960004375 ciclopirox olamine Drugs 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- ZCPCLAPUXMZUCD-UHFFFAOYSA-M dihexadecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC ZCPCLAPUXMZUCD-UHFFFAOYSA-M 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- UCYFZDNMZYZSPN-UHFFFAOYSA-N docosyl(trimethyl)azanium Chemical class CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C UCYFZDNMZYZSPN-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- TVFJAZCVMOXQRK-UHFFFAOYSA-N ethenyl 7,7-dimethyloctanoate Chemical compound CC(C)(C)CCCCCC(=O)OC=C TVFJAZCVMOXQRK-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019277 ethyl gallate Nutrition 0.000 description 1
- 239000001734 eugenia caryophyllata l. bud oleoresin Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960001274 fenticonazole Drugs 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 229960001235 gentian violet Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- UHUSDOQQWJGJQS-UHFFFAOYSA-N glycerol 1,2-dioctadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCCCC UHUSDOQQWJGJQS-UHFFFAOYSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- 230000003700 hair damage Effects 0.000 description 1
- 229960001906 haloprogin Drugs 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920013818 hydroxypropyl guar gum Polymers 0.000 description 1
- 229940027897 ichthammol Drugs 0.000 description 1
- 238000005417 image-selected in vivo spectroscopy Methods 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 239000002418 insect attractant Substances 0.000 description 1
- 238000012739 integrated shape imaging system Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960004849 isoconazole Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 229950010163 lanoconazole Drugs 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940044591 methyl glucose dioleate Drugs 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- UTTVXKGNTWZECK-UHFFFAOYSA-N n,n-dimethyloctadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)[O-] UTTVXKGNTWZECK-UHFFFAOYSA-N 0.000 description 1
- 229940049292 n-(3-(dimethylamino)propyl)octadecanamide Drugs 0.000 description 1
- KKBOOQDFOWZSDC-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCN(CC)CC KKBOOQDFOWZSDC-UHFFFAOYSA-N 0.000 description 1
- XNJXGLWSAVUJRR-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCN(C)C XNJXGLWSAVUJRR-UHFFFAOYSA-N 0.000 description 1
- DYAVLIWAWOZKBI-UHFFFAOYSA-N n-[3-(diethylamino)propyl]hexadecanamide Chemical compound CCCCCCCCCCCCCCCC(=O)NCCCN(CC)CC DYAVLIWAWOZKBI-UHFFFAOYSA-N 0.000 description 1
- KUIOQEAUQATWEY-UHFFFAOYSA-N n-[3-(diethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(CC)CC KUIOQEAUQATWEY-UHFFFAOYSA-N 0.000 description 1
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- JPMIIZHYYWMHDT-UHFFFAOYSA-N octhilinone Chemical compound CCCCCCCCN1SC=CC1=O JPMIIZHYYWMHDT-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920002601 oligoester Polymers 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 229960004031 omoconazole Drugs 0.000 description 1
- JMFOSJNGKJCTMJ-ZHZULCJRSA-N omoconazole Chemical compound C1=CN=CN1C(/C)=C(C=1C(=CC(Cl)=CC=1)Cl)\OCCOC1=CC=C(Cl)C=C1 JMFOSJNGKJCTMJ-ZHZULCJRSA-N 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 229960002894 oxiconazole nitrate Drugs 0.000 description 1
- WVNOAGNOIPTWPT-NDUABGMUSA-N oxiconazole nitrate Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1CO\N=C(C=1C(=CC(Cl)=CC=1)Cl)/CN1C=NC=C1 WVNOAGNOIPTWPT-NDUABGMUSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000013500 performance material Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229910052615 phyllosilicate Inorganic materials 0.000 description 1
- 229940068124 pine tar Drugs 0.000 description 1
- 239000011297 pine tar Substances 0.000 description 1
- 229920002553 poly(2-methacrylolyloxyethyltrimethylammonium chloride) polymer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- GGOZGYRTNQBSSA-UHFFFAOYSA-N pyridine-2,3-diol Chemical compound OC1=CC=CN=C1O GGOZGYRTNQBSSA-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical group 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 229940081623 rose bengal Drugs 0.000 description 1
- 229930187593 rose bengal Natural products 0.000 description 1
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 229960004476 sertaconazole nitrate Drugs 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960004718 sulconazole nitrate Drugs 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
- 229960000580 terconazole Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003558 thiocarbamic acid derivatives Chemical class 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 229960004214 tioconazole Drugs 0.000 description 1
- 150000003852 triazoles Chemical group 0.000 description 1
- PDSVZUAJOIQXRK-UHFFFAOYSA-N trimethyl(octadecyl)azanium Chemical class CCCCCCCCCCCCCCCCCC[N+](C)(C)C PDSVZUAJOIQXRK-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- MQWLIFWNJWLDCI-UHFFFAOYSA-L zinc;carbonate;hydrate Chemical compound O.[Zn+2].[O-]C([O-])=O MQWLIFWNJWLDCI-UHFFFAOYSA-L 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
- A61K8/898—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
本发明涉及用于减少毛发卷曲的洗去型调理剂组合物,所述洗去型调理剂组合物包含约0.2%至约20.0%的水分控制材料或水分控制材料的混合物,其中所述水分控制材料选自以下中的一种或多种:其中R’为‑COOY、磺酸、或C=CH‑COOY,Y为氢或金属离子,R1、R2、R3、R4、R5为氢、甲基、乙基、丙基、乙烯基、烯丙基、甲氧基、乙氧基、羟基、卤素、硫酸根、磺酸根、硝基、或‑CH=CH‑COOR,并且其中所述水分控制材料为酸性材料,并且进一步地,其中所述水分控制材料具有高于20的蛋白结合%和低于500的分子体积,以及低于3的辛醇与水的分配系数(log P)和高于10的氢结合以及低于5.0的pKa;以及与不含所述水分控制材料的对照组合物相比至少约4%的卷曲减少。
Description
技术领域
本发明涉及洗去型调理剂组合物,该洗去型调理剂组合物包含一种或多种可用于处理毛发卷曲的材料。
背景技术
消费者将毛发卷曲描述成头皮顶部和毛发尖部的纤维难以控制以及穿过大量毛发的体积增加的外观。一般来讲,在出现潮湿天气并且空气中水分含量较高的日子中,他们会看到此种卷曲。卷曲的外观是不期望的,并且其通常与光泽和光滑度的丧失相关联。卷曲的外观以及光泽和光滑度的丧失与较差的毛发健康感觉相关联。在高度潮湿环境中导致卷曲的基本机制在于当高湿度水渗入毛发时,毛发内部的化学键相互作用发生变化。在定型期间,消费者将创建使毛发吹干或熨发的“润湿设定”,以形成期望的形状。在干燥期间,水从毛发蒸发掉并在蛋白质肽链之间形成氢键,从而将发型固定在适当的位置。当水分扩散到毛发中时,氢键断裂并且毛发返回其自然形状。对于通过吹干或烫发来拉直其毛发的消费者而言,这种回到卷曲样式与调准失败和体积增大相关联。此外,在毛发中水分含量较高时,纤维直径增大,这也会增大毛发的总体积。
防止卷曲的典型策略是配制调理剂产品,其具有使毛发更疏水并且减小纤维间相互作用的表面沉积材料,诸如硅氧烷、油、调理硅氧烷等。在高水平下,这些材料也可提供增大的内聚力而使纤维保持在一起,从而防止卷曲发生。在这些材料沉积在毛发表面上的情况下,通常会经历油腻的外观和感觉,这是降低卷曲的不期望的权衡。
因此,需要调理剂产品,该调理剂产品将有效的卷曲控制与消费者可注意和感觉的附加毛发有益效果相结合,同时使用起来令人愉悦而无粘着感和油腻感。
发明内容
在一个实施方案中,用于减少毛发卷曲的洗去型调理剂组合物包含:
约0.2%至约20%的水分控制材料或水分控制材料的混合物,其中所述水分控制材料选自以下中的一种或多种:
其中R’为-COOY、磺酸、或C=CH-COOY,Y为氢或金属离子,R1、R2、R3、R4、R5为氢、甲基、乙基、丙基、乙烯基、烯丙基、甲氧基、乙氧基、羟基、卤素、硫酸根、磺酸根、硝基、或-CH=CH-COOR,并且其中所述水分控制材料为酸性材料,并且进一步地,其中所述水分控制材料具有高于20的蛋白结合%和低于500的分子体积,以及低于3的辛醇与水的分配系数(logP)和高于10的氢结合以及低于5.0的pKa;以及与不含水分控制材料的对照组合物相比至少约4%的卷曲减少。
不受理论的约束,本发明的调理剂处理组合物中的材料提供优异的卷曲性能,而不会不利影响毛发感觉。这些材料防止水在高湿度条件下吸收到毛发中,从而降低卷曲的负面影响。通过渗入毛发纤维而非沉积在毛发表面上提供卷曲有益效果,卷曲有益效果不与负面毛发感觉相关联,其通常在目前市售的抗卷曲产品中被观察到。根据以下详细描述,将更全面地理解由本发明的实施方案所提供的这些和附加的特征。
附图说明
图1为描绘水减少%与卷曲减少%之间存在单调相关性的图示。
具体实施方式
除非另外指明,本文中使用的所有百分比和比率均按所述组合物总体的重量计。除非另外指明,所有测量均被理解为是在环境条件下进行,其中“环境条件”是指在约25℃下,在约一个大气压下,并且在约50%相对湿度(RH)下的条件。所有数值范围是包括端值在内的较窄范围;所描述的范围上限和下限是可组合的,以形成没有明确描述的另外的范围。
本发明的组合物可包含本文所描述的基本组分以及任选成分,基本上由或由本文所描述的基本组分以及任选成分组成。如本文所用,“基本上由...组成”是指组合物或组分可包含附加成分,只要该附加成分不在本质上改变受权利要求书保护的组合物或方法的基本特征和新颖特征。
如关于组合物所用的“施加”或“施用”是指将本发明的组合物施加或铺展到角质组织诸如毛发上。
“皮肤病学可接受的”是指所述组合物或组分适用于与人的皮肤组织接触,而没有不适当的毒性、不相容性、不稳定性、变应性应答等。
“安全有效量”是指足以显著地诱导积极的有益效果的化合物或组合物的量。
“对照组合物”为用于与本发明组合物进行性能方面比较的组合物。通常,对照组合物和本发明组合物在成分和浓度方面非常相似,不同之处在于对照组合物不含构成本发明的一种或多种材料。因此,存在于本发明组合物中的一种或多种本发明材料被对照组合物中的载体取代,或在本发明时期被本领域中常见的材料取代。
与组合物相关的“洗去型”是指组合物旨在施用于角质基质,随后通过在施用几分钟或更短时间内洗涤、冲洗或擦拭而除去。这些“洗去型”组合物与旨在施用于角质组织并且允许保留在角质组织上的“免洗型”组合物不同。
最常见的毛发护理洗去型组合物是洗发剂和洗去型调理剂。洗发剂包含去污表面活性剂,并且它们用于清洁毛发,而洗去型调理剂通常在洗发剂之后使用,它们基本上不含去污表面活性剂,它们包含调理剂以改善毛发感觉,逆转毛发损伤,并且防止进一步的损伤。
与组合物相关的“免洗型”是指旨在施用于角质组织并且允许保留在角质组织上的组合物。这些免洗型组合物区别于施用于毛发并且随后(几分钟或更短时间内)通过洗涤、冲洗、擦拭等除去的组合物。免洗型组合物不包括洗去型应用,诸如洗发剂、洗去型调理剂、面部清洁剂、洗手液、沐浴剂、或身体沐浴露。免洗型组合物可基本上不含清洁或去污表面活性剂。例如,“免洗型组合物”可在角质组织上保留至少15分钟。例如,免洗型组合物可包含少于1%的去污表面活性剂,少于0.5%的去污表面活性剂,或0%的去污表面活性剂。然而,组合物可包含乳化、分散或其它加工表面活性剂,当局部施用于毛发时,其不旨在提供任何显著的清洁有益效果。
“可溶性”是指在25℃和1atm的压力下,至少约0.1g的溶质溶解于100mL的溶剂中。
除非另外说明,所有百分比均按组合物总体的重量计。除非另外特别说明,所有比率均为重量比。所有范围均包括端值在内并且可组合。有效数字的数表示既不表达对所示量的限制,也不表达对测量精确性的限制。除非另外指明,如本文所用,术语“分子量”或“M.Wt.”是指重均分子量。可通过凝胶渗透色谱法来测量重均分子量。“QS”是指足量至100%。
如本文所用,术语“基本上没有”或“基本上不含”是指按所述组合物的总重量计小于约1%,或小于约0.8%,或小于约0.5%,或小于约0.3%,或约0%。
如本文所用,“毛发”是指哺乳动物毛发,包括头皮毛发、面部毛发和躯体毛发,尤其是人头部和头皮上的毛发。
如本文所用,“美容上可接受的”是指所述组合物、制剂或组分适用于与人类的角质组织接触,而没有不适当的毒性、不相容性、不稳定性、变应性应答等。旨在直接施用于角质组织的本文所述的所有组合物限于美容上可接受的那些。
如本文所用,“衍生物”包括但不限于给定化合物的酰胺、醚、酯、氨基、羧基、乙酰基、酸、盐和/或醇衍生物。
如本文所用,“聚合物”是指由两种或更多种单体的聚合而形成的化学物质。如本文所用,术语“聚合物”应该包括由单体的聚合制成的所有材料以及天然的聚合物。仅由一种类型的单体制成的聚合物称为均聚物。由两种或更多种不同类型单体制成的聚合物称为共聚物。可统计学地或分块计算不同单体的分布--两种可能性均适用于本发明。除非另外说明,本文所用的术语“聚合物”包括任何类型的聚合物,包括均聚物和共聚物。
产生卷曲的作用机制包括环境中的水分被毛发吸收并占据毛发内部的氢键合位置(包括肽主链上的那些),并且还与氨基酸残基诸如赖氨酸、精氨酸和谷氨酸的酸性和碱性侧链相关联。该内部水替换使毛发保持为期望构型的定型期间所产生的氢键。因此,毛发回到其自然形状,这通常导致不需要的波纹,丧失调准并且卷曲。此外,这些氢键合位置所吸收的水使毛发纤维溶胀,从而导致样式膨胀,这是卷曲的另一个标志。不受理论的约束,本发明涵盖的材料将替换毛发内部氢键位置处的水并防止水吸收。毛发内部的水减少将导致高湿度条件下卷曲外观的减少。因为作用机制与毛发纤维内部的空间相关,所以不存在负面感觉,诸如例如与有益效果相关联的油腻感或油性感。水吸收的减少采用动态蒸气吸附(DVS)方法进行测量,其测量在0%相对湿度(RH)相对于90%RH下平衡的毛发的重量增加。测量经材料处理的毛发的显著卷曲有益效果,所述经材料处理的毛发相对于未经此类材料处理的对照毛发导致水吸收减少高于5%。该处理包括施用在50:50的水:乙醇溶剂中含2%w/w材料的溶液。
优选的材料包括水杨酸、2,3-二羟基苯甲酸、2,6-二羟基苯甲酸、3-氨基苯甲酸、没食子酸、没食子酸乙酯、5-氯水杨酸、反式阿魏酸、对香豆酸、蓖麻油酸、异戊酸、异丁酸、2-己基-1-癸醇、植醇和脱水山梨糖醇辛酸酯。这些材料选自I类分子和/或II类分子,或者也可组合使用以增加有益效果的程度。
在本发明的一个实施方案中,毛发调理剂组合物中水分控制材料的浓度或水分控制材料的混合物的浓度为约0.2%至约20%,在一个实施方案中为约0.5%至约8.0%,并且在另一个实施方案中为约0.5%至约5.0%。
I类分子:具有以下特性的极性酸性化合物:蛋白结合(PB)>20并且分子体积(Mol.Vol)<500,并且logP<3,并且氢结合(H-结合)>10,并且pKa<5.0,其中PB为蛋白结合%,Mol.Vol为分子体积(以计);log P为正辛醇/水分配系数。这些特性可用Volsurf软件(http://www.moldiscovery.com/soft_volsurf.php)计算。H键为得自Hansen溶解度参数的分子间氢键的能量,并且pKa值为酸解离常数的对数量度。
b)II类分子:弱极性至非极性、弱酸性至非酸性的化合物,具有以下特性:PB>10,并且Mol.Vol.<1500,并且log P>0.5,并且pKa≥5,并且H-结合>4,其中PB为蛋白结合%,Mol.Vol为分子体积(以计);logP为正辛醇/水分配系数。这些特性可用Volsurf软件(http://www.moldiscovery.com/soft_volsurf.php)计算。H键为得自Hansen溶解度参数的分子间氢键的能量,并且pKa值为酸解离常数的对数量度。
第I类具有选自以下的结构:
1)第I类,其具有选自以下的结构:
其中R’为-COOY、磺酸或-C=CH-COOY,Y为氢或金属离子,R1、R2、R3、R4、R5为氢、甲基、乙基、丙基、乙烯基、烯丙基、甲氧基、乙氧基、羟基、卤素、硫酸根、磺酸根、硝基或-CH=CH-COOR,并且其中水分控制材料为酸性材料,并且进一步地,其中水分控制材料具有高于20的蛋白结合%,和低于500的分子体积,和低于3的辛醇与水的分配系数(log P),和高于10的氢结合以及低于5.0的pKa;
2)第II类,其具有选自以下的结构:
a)
其中R为氢或金属离子,R6为具有少于12个碳原子的甲基、乙基、丙基、烯基或苯基,并且其中R7、R8、R9、R10、R11、R12为氢、甲基、乙基、丙基、苯基、羟基、甲氧基或乙氧基基团;
b)
醇,其中R13为烷基、烯基、直链或支链的碳链;并且其中R14为氢、羟基、烷基、甲基、乙基和丙基,其中此类醇的结构包含少于20个总碳原子;
c)在C2位包含不饱和双键的醇。非限制性示例将为植醇。
d)烷基取代的二醇,其中此类烷基取代的二醇的结构包含少于20个碳原子;
e)单烷基或二烷基取代的甘油或者甘油与脂肪酸的单酯或二酯,其中此类单烷基或二烷基取代的甘油或者甘油酯的结构包含少于20个总碳原子;
f)
其中R15可为氢、烷基、烯基、苯基基团,并且其中R13基团的结构包含少于20个碳原子;
g)包含15至40个总碳原子的脂肪酸酯,
并且其中第II类水分控制材料呈弱酸性至非酸性,并且进一步地,
其中第II类水分控制材料具有高于10的蛋白结合和低于1500的分
子体积和高于0.5的logP和5或更高的pKa以及高于4的氢结合。
组合物的pH
下文是用各种pH值下包含1%水杨酸的乙醇:水(50:50)溶液的免洗型组合物处理的毛发相对于对照(用乙醇:水(50:50)的组合物处理的毛发)的水减少%的差值数据。如在下表中所示,本发明示出相比于更高pH,在更低pH下具有改善的性能。
配方实施例 | pH 3 | pH 4.2 | pH 7 | pH 10 |
原材料 | ||||
蒸馏水 | 适量 | 适量 | 适量 | 适量 |
乙醇 | 50.0 | 50.0 | 50.0 | 50.0 |
水杨酸 | 1.0 | 1.0 | 1.0 | 1.0 |
最终pH | 3.2 | 4.2 | 7 | 10 |
水减少% | 30 | 27 | 22 | 15 |
在本发明的一个实施方案中,包含来自I类分子的材料的本发明组合物的pH可在约1至约9的范围内,在另一个实施方案中,pH为约2至约7,在另一个实施方案中,pH为约4至约5.5。
在本发明的一个实施方案中,水分控制材料为羧酸酯。在一个实施方案中,羧酸酯基于脂肪酸,其中脂肪酸的分子包含多于14个碳原子。此类酯的非限制性示例为异硬脂酸异硬脂醇酯、硬脂酸甲酯、棕榈酸甲酯和油酸甲酯。在本发明的另一个实施方案中,羧酸酯为使用甲醇通过使天然油反应而制备的物质的混合物的一部分。此类混合物的非限制性示例为使精炼棕榈仁油与甲醇反应,之后经由蒸馏进行分馏所得产物而产生的混合物。满足本说明书的商业产品为Heavy Cut Ester CE-1875(由P&GChemicals供应,CAS号6772-38-3),其包含成分:诸如硬脂酸甲酯、棕榈酸甲酯、油酸甲酯作为主要成分,以及月桂酸甲酯、肉豆蔻酸甲酯、山嵛酸甲酯及其它物质作为次要成分。
制剂和实施例
以下为本发明的非限制性实施例。实施例的给出仅是为了举例说明目的,不应被解释为是对本发明的限制,因为在不脱离本发明的实质和范围的情况下,其许多变型是可能的,这将被本领域的普通技术人员所认识到。
实施例
洗去型调理剂组合物制备:
洗去型调理剂组合物可由在本领域中熟知的任何常规方法制得。将阳离子表面活性剂与脂肪醇混合在一起,并且加热到约66℃至约85℃,以形成油相。单独混合乙二胺四乙酸二钠、甲基氯异噻唑啉酮(防腐剂)和水,并且加热到约20℃至约48℃以形成水相。在高剪切下将油相混合到水相中,以形成凝胶基质。在搅拌下将其余组分加入到凝胶基质中。然后使该组合物冷却至室温。
表1:洗去型调理剂制剂
1.由Feixiang Chemicals(Zhangjingang)Co.,Ltd.供应
2.由P&G Chemicals供应
3.由P&G Chemicals供应
4.由Ineos Maastricht BV(Maastricht NL)供应
5.Trilon BD粉末,由BASF SE(Ludwigshafen,DE)供应
6.Kathon CG,由Rohm&Haas Co(Philadelphia US)供应
7.Y-14945,由Momentive Performance Materials供应
8.由API Corpotration供应
9.由Sigma Algrich供应
10.由Sigma Algrich供应
11.Crodamol ISIS,由Croda供应
12.Isofol 16,由Sasol(Brunsbuettel,DE)供应
13.Greenolene 6928,由Green Oleo供应
洗去型调理剂毛发处理方案:
所有测试均在重约4.0克并且长约6英寸的白种人受损卷曲发簇上进行。所述发簇可从IHIP(International Hair Importers)商购获得。每洗去型组合物每剂量使用三个发簇。每个发簇用深层清洁洗发剂洗涤,然后根据以下方案用洗去型调理剂处理。
通过注射器将0.20g量的深层清洁洗发剂铺展到单独的发簇上。即剂量为每克毛发0.10g洗发剂。每次施用包括向毛发添加洗发剂,乳化30秒,然后冲洗30秒。然后重新施用洗发剂(0.1g/g),乳化30秒并且冲洗30秒。自发簇挤出过量的水,然后施用0.1g/g洗去型调理剂并且乳化30秒,接着冲洗30秒。
将该方案重复5次/循环。
评估方法
使用以下方法评估用洗去型调理剂组合物处理的发簇。
a.DVS测量
在将毛发暴露于洗去型调理剂处理之后,使用动态蒸气吸附(DVS)方法,根据以下规程,将其吹干并且分析作为相对湿度(RH)的函数的水吸附-解吸。更具体地,将发簇称重,并且在0%RH下保持平衡16小时。在16小时时间段之后,将RH增至10%并在该水平下维持6小时。然后,在每6小时间隔后使RH增加10%,直至其达到90%RH。如下计算水减少%:
A=用包含水分控制材料的组合物处理的毛发吸收的水量
B=用不含水分控制材料的对照组合物(仅载体)处理的毛发吸收的水量
水减少%=[(B-A)×100]/B
DVS测量的标准误差小于0.05
b.卷曲减少的测定
在用洗去型调理剂处理后,将发簇充分吹干,同时保持发簇,使所有毛发纤维位于发梢,然后通过将毛发切成三份,接着用直发电烫筒将发簇在400F-450F下进行8次加热来加热拉直。然后将发簇保持在低湿度(介于20%-25%RH之间)下,平衡至少一个小时。平衡期后,将发簇转移至高湿度室(85%-90%RH),进行卷曲评定。使用具有平行偏振器的NIR照相机,在将毛发插入高湿度室(t0)后立即拍摄发簇图像。另一个图像在3小时后(t3h)拍摄。分析像素(选择整个发簇),进行2D体积投影(使用vncviewer软件)。然后测定t0时发簇的平均投影面积(At0)和t3h时毛发的平均投影面积(At3h),并且使用下文给出公式计算卷曲。用3个发簇重复每个实验。使用下文公式计算卷曲百分比:
卷曲%=100×(At3h At0/At0)
卷曲减少%=100×(卷曲%(本发明组合物)-卷曲%(对照组合物)/卷曲%(对照组合物)
卷曲测量的标准误差小于0.1。
由DVS方法测定的卷曲减少%相对于水减少%的相关性
得自DVS测量的结果和得自各发簇的卷曲减少方法的测定的结果表明,两种方法之间存在相关性。换句话讲,如图1中所示,显示低水分降低的发簇也显示较低的卷曲。
图1示出了水减少%相对于卷曲减少%的相关性,其中处理具有不同剂量的发簇,并且分别使用DVS和卷曲方法测量它们的水减少%和卷曲减少%。
图1为示出水减少%与卷曲减少%之间存在单调相关性的曲线图。随着材料剂量的增加,水减少%增加,导致卷曲减少%增加,即更大的卷曲控制。
结果
如图1所示,水减少%与卷曲减少%之间存在单调相关性。随着材料剂量增加,更多的材料渗入毛发。高湿度下的水减少%增加,导致卷曲减少%增加,即更大的卷曲控制。这证实了本发明的技术假说:材料渗透、与毛发蛋白质的相互作用以及高湿度下毛发内吸水量的降低导致卷曲控制。
免洗型处理组合物制备:
通过将水分控制材料和香料(如果需要的话)添加到50:50乙醇/水载体中并搅拌直至完全溶解来制备免洗型处理组合物。用氢氧化钠(50%w/w)将溶液pH调节至4.0-4.2的最终pH。然后添加Sepigel 305(如果需要的话),并使用高速混合器在1800rpm-2300rpm下混合溶液2-5分钟,直至获得均匀组合物。
免洗型毛发处理方案:
经由注射器将量为0.20g的实施例I至IV中各组合物铺展于重量为2.0g的独立天然原始棕色发簇上(剂量为0.10g溶液/g毛发)。使毛发风干,然后用上述DVS方法进行分析。对于0.50g溶液/g毛发的剂量,重复该实验。如下所述,除DVS分析之外,专家评级师还对该情况下的毛发进行评定。
发簇感觉评定方法:使经处理的发簇在高湿度(高于85%Rh)下保持2小时,然后要求十名专家评级师基于5分制根据触感对其每一者进行评级,5为最高(最佳感觉)并且1为最低等级。
免洗型处理制剂:
结果:配方I至XIII示出高湿度下的水减少%。在用更高剂量的免洗型配方I-XIII处理的毛发中,观察到更高的水减少%。
感觉评定结果示出以下项的组合:
(a)5-氯水杨酸和2-己基-1-癸醇;
(b)5-氯水杨酸和异硬脂酸异硬脂醇酯;
(c)5-氯水杨酸和2-己基-1-癸醇以及异硬脂酸异硬脂醇酯
不仅提供了水吸收减少(导致卷曲有益效果),而且提供触感有益效果。这通过(a)实施例XI对实施例VIII和IX,(b)实施例XII对实施例VIII和X,以及(c)实施例XIII对实施例VIII、IX和X的感觉比较示出。
附加评估
根据上述规程制备另外的免洗型处理组合物(表1和表2),采用上述规程使用该组合物处理发簇(量为0.10g组合物/g毛发)。将发簇在高湿度(高于85%)下保持2小时。然后,要求十名专家基于5分制,根据卷曲、清洁感和油腻感对各个发簇进行评级,5为最高,并且1为最低等级。可接受的值为:
·对于卷曲,小于2(较低的数字对应较少的卷曲);
·对于无油腻的感觉,小于3,(较低的数字对应较少油腻感),并且
·对于清洁感,大于3(较高的数字对应更清洁的感觉)。
表1:第I类化合物
得自I类分子的发簇评级结果:来自I类的分子(5-氯水杨酸、水杨酸、4-羟基苯磺酸、2,4-二羟基苯甲酸)提供毛发有益效果。更具体地,表1示出,与用末端氨基硅氧烷处理相反(提供一些卷曲有益效果但具有负面油腻感和显著较小的清洁感),采用5-氯水杨酸、水杨酸、4-羟基苯磺酸和2,4-二羟基苯甲酸的毛发处理提供卷曲保护与清洁感而且无负面油腻感。
表2:第II类化合物
配方实施例 | 对照物 | XIX | XX | XXI | XXII | XXIII |
原材料 | ||||||
蒸馏水 | 50.0% | 49.5% | 49.5% | 49.5% | 49.5% | 49.5% |
乙醇 | 50.0% | 49.5% | 49.5% | 49.5% | 49.5% | 49.5% |
异硬脂酸异硬脂醇酯 | 0% | 1% | 0% | 0% | 0% | 0% |
水杨酸2-羟乙酯 | 0% | 0% | 1% | 0% | 0% | 0% |
水杨酸辛酯 | 0% | 0% | 0% | 1% | 0% | 0% |
2-己基-1-癸醇 | 0% | 0% | 0% | 0% | 1% | 0% |
末端氨基硅氧烷 | 0% | 0% | 0% | 0% | 0% | 1% |
组合物pH,调节至 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 |
油腻感 | 2 | 2 | 2 | 2 | 3 | 4 |
卷曲 | 4 | 2 | 2 | 1 | 1 | 3 |
清洁感 | 4 | 3 | 3 | 3 | 3 | 1 |
得自II类分子的发簇评级结果:来自II类的分子(异硬脂酸异硬脂醇酯、水杨酸2-羟乙酯、水杨酸辛酯、2-己基-1-癸醇)提供毛发有益效果。更具体地,表2示出,与用末端氨基硅氧烷处理相反(提供一些卷曲有益效果但具有负面油腻感和显著较小的清洁感),采用异硬脂酸异硬脂醇酯、水杨酸2-羟乙酯、水杨酸辛酯和3-己基-1-癸醇的毛发处理提供卷曲保护与清洁感而且无负面油腻感。
毛发摩擦的评估
包含水分控制材料和硅油的免洗型制剂相较于未经处理的毛发示出改善的干燥感。这通过测量干发摩擦来进行。对于该评估,天然原始棕色发簇(4.0g)用深层清洁洗发剂洗涤,并然后根据上述方案用免洗型处理组合物XXIV处理。在评估之前,使发簇在受控的温度和湿度室(22℃/50%RH)中空气干燥过夜。沿毛发测量毛发表面与聚氨酯垫之间的摩擦力(克),使用Instron Tester仪器(Instron 5542,Instron,Inc,Canton,Mass.,USA)对每个发簇测量三次。
表3:毛发摩擦
配方实施例 | XXIV | 对照毛发—未处理 |
原材料 | ||
蒸馏水 | 49.5% | |
乙醇 | 49.5% | |
2,4-二羟基苯甲酸 | 1% | |
硅油 | 0% | |
组合物pH,调节至 | 4.2 | |
平均力(g) | 40 | 55 |
如表3所示,用包含水分控制材料和硅油的免洗型组合物处理毛发导致毛发摩擦减小,这表明干燥感得到改善。
已知天然存在于毛发内部的有机疏水分子(例如,作为细胞膜复合脂质的一部分)有助于其强度和完整性。还已知,美容护理诸如氧化性着色和持久定型导致毛发中此类疏水性材料的浓度降低。因此,疏水性材料(例如,第II类材料)渗入毛发内部可有助于脂质补充(其同时降低对递送水分的水吸收)或卷曲控制有益效果。不同的第II类材料(例如苄醇、2-己基-1-癸醇、异硬脂酸异硬脂醇酯)的组合具有渗透的多功能性,嵌入毛发脂质并且还可增加其它疏水性材料(如油酸)的渗透,从而导致毛发内部的疏水性进一步增大。
毛发内部水分控制材料的渗透
在本发明的一个实施方案中,组合物可包含二醇、聚二醇、脲、醚或它们的混合物。这些材料增加水分控制活性物质诸如水杨酸、5-氯水杨酸的渗透,从而改善其性能。丙二醇、丁二醇以及其它二醇增加毛发内部5-氯水杨酸的渗透,原因是其充当活性物质的载体以进一步渗透。随着活性物质渗透增加,活性物质的功效增大,即水减少%有所增大,如下表4所示。表4示出用两种不同的组合物处理毛发之后渗入氧化损伤的毛发内部的5-氯水杨酸的量。其还示出相对于用对照免洗型处理组合物处理的处理后所观察到的水减少%。这些结果表明,在丙二醇存在下,5-氯水杨酸渗透是没有丙二醇的情况的4倍,并且水减少%(如由DVS所测)的增加是没有丙二醇的情况的约4倍。使水分控制材料渗透增强的材料的另一个示例为2-羟乙基脲。与不含2-羟乙基脲的对应组合物相比,包含2%的2-羟乙基脲的免洗型处理组合物使毛发内部的水杨酸的渗透增加14%(参见实施例XXVII和XXVIII)。
使用以下方案测定5-氯水杨酸的渗透量。各个发绺用含0.1%TFA(三氟乙酸)的甲醇提取3次,并且用HPLC方法分别分析各个提取物。
除增加水分控制材料的渗透量之外,组合物中存在的二醇还防止毛发表面中的部分水分控制材料结晶。此类结晶导致不光滑的负面发感,这可被消费者在毛发受损或缺乏调理时感知到。
已观察到,在本发明的一个实施方案中,丙二醇的存在可为第I类和第II类分子材料提供渗透增强。
调理剂组合物
本发明的个人护理组合物包含阳离子表面活性剂、高熔点脂肪族化合物和含水载体。表面活性剂、高熔点脂肪族化合物和含水载体为乳液形式。
阳离子表面活性剂体系
本发明的组合物包含阳离子表面活性剂体系。该阳离子表面活性剂体系可为一种阳离子表面活性剂或者两种或更多种阳离子表面活性剂的混合物。优选地,阳离子表面活性剂体系选自:单长链烷基季铵化铵盐;单长链烷基季铵化铵盐和双长链烷基季铵化铵盐的组合;单长链烷基酰氨基胺盐;单长链烷基酰氨基胺盐和双长链烷基季铵化铵盐的组合、单长链烷基酰氨基胺盐和单长链烷基季铵化铵盐的组合。
阳离子表面活性剂体系在所述组合物中的含量为约0.1重量%至约10重量%,优选地约0.5重量%至约8重量%,更优选地约0.8重量%至约5重量%,还更优选地约1.0重量%至约4重量%。
单-长链烷基季铵化铵盐
可用于本文的单烷基季铵化铵盐阳离子表面活性剂是具有一条长烷基链的那些,所述长烷基链具有12至30个碳原子,优选地16至24个碳原子,更优选地C18-22烷基基团。与氮连接的其余基团独立地选自具有1至约4个碳原子的烷基基团、或具有至多约4个碳原子的烷氧基、聚氧化亚烷基、烷基酰氨基、羟烷基、芳基或烷基芳基基团。
可用于本文的单长链烷基季铵化铵盐是具有式(I)的那些:
其中R75、R76、R77和R78中的一者选自具有12至30个碳原子的烷基基团,或具有至多约30个碳原子的芳族基团、烷氧基、聚氧化亚烷基、烷基酰氨基、羟烷基、芳基或烷芳基基团;R75、R76、R77和R78中的其余基团独立地选自具有1至约4个碳原子的烷基基团,或具有至多约4个碳原子的烷氧基、聚氧化亚烷基、烷基酰氨基、羟烷基、芳基或烷基芳基基团;并且X-为成盐阴离子,诸如选自卤素(例如氯、溴)、乙酸根、柠檬酸根、乳酸根、乙醇酸根、磷酸根、硝酸根、磺酸根、硫酸根、烷基硫酸根和烷基磺酸根的那些。除了碳原子和氢原子之外,烷基基团还可包含醚键和/或酯键,以及其它基团诸如氨基基团。长链烷基基团例如具有约12个或更多个碳原子的那些可为饱和或不饱和的。优选地,R75、R76、R77和R78中的一者选自具有12至30个碳原子,更优选地16至24个碳原子,还更优选地18至22个碳原子,甚至更优选地22个碳原子的烷基基团;R75、R76、R77和R78中的其余基团独立地选自CH3、C2H5、C2H4OH、以及它们的混合物;并且X选自Cl、Br、CH3OSO3、C2H5OSO3、以及它们的混合物。
此类单长链烷基季铵化铵盐阳离子表面活性剂的非限制性示例包括:二十二烷基三甲基铵盐;硬脂基三甲基铵盐;鲸蜡基三甲基铵盐;和氢化牛脂烷基三甲基铵盐。
单长链烷基酰氨基胺盐
单长链烷基胺也适用作阳离子表面活性剂。脂肪族伯胺、脂肪族仲胺和脂肪族叔胺是可用的。尤其可用的是具有包含约12至约22个碳原子的烷基基团的叔酰氨基胺。示例性的叔酰氨基胺包括:硬脂酰氨基丙基二甲基胺、硬脂酰氨基丙基二乙基胺、硬脂酰氨基乙基二乙基胺、硬脂酰氨基乙基二甲基胺、棕榈酰氨基丙基二甲基胺、棕榈酰氨基丙基二乙基胺、棕榈酰氨基乙基二乙基胺、棕榈酰氨基乙基二甲基胺、二十二烷酰氨基丙基二甲基胺、二十二烷酰氨基丙基二乙基胺、二十二烷酰氨基乙基二乙基胺、二十二烷酰氨基乙基二甲基胺、二十烷酰氨基丙基二甲基胺、二十烷酰氨基丙基二乙基胺、二十烷酰氨基乙基二乙基胺、二十烷酰氨基乙基二甲基胺、二乙基氨基乙基硬脂酰胺。本发明中可用的胺公开于Nachtigal等人的美国专利4,275,055中。这些胺也可与酸组合使用,所述酸诸如l-谷氨酸、乳酸、盐酸、苹果酸、琥珀酸、乙酸、富马酸、酒石酸、柠檬酸、l-谷氨酸盐酸盐、马来酸、以及它们的混合物;更优选地l-谷氨酸、乳酸、柠檬酸。本文的胺优选地被这些酸中的任何一者部分中和,胺与酸的摩尔比为约1:0.3至约1:2,更优选地约1:0.4至约1:1。
二长链烷基季铵化铵盐
二长链烷基季铵化铵盐优选地与单长链烷基季铵化铵盐或单长链烷基酰氨基胺盐组合。据信,与单独使用单烷基季铵化铵盐或单长链烷基酰氨基胺盐相比,此类组合可提供易于漂洗感。在与单长链烷基季铵化铵盐或单长链烷基酰氨基胺盐的此类组合中,使用一定含量的二长链烷基季铵化铵盐,使得二烷基季铵化铵盐在所述阳离子表面活性剂体系中的重量%优选地在约10%至约50%的范围内,更优选地在约30%至约45%的范围内。
可用于本文的二烷基季铵化铵盐阳离子表面活性剂是具有两个长烷基链的那些,所述长烷基链具有12-30个碳原子,优选地16-24个碳原子,更优选地18-22个碳原子。与氮连接的其余基团独立地选自具有1至约4个碳原子的烷基基团、或具有至多约4个碳原子的烷氧基、聚氧化亚烷基、烷基酰氨基、羟烷基、芳基或烷基芳基基团。
可用于本文的双长链烷基季铵化铵盐是具有式(II)的那些:
其中R75、R76、R77和R78中的两个选自具有12至30个碳原子的烷基、或具有至多约30个碳原子的芳族基团、烷氧基、聚氧化亚烷基、烷基酰氨基、羟烷基、芳基或烷基芳基基团;R75、R76、R77和R78中的其余基团独立地选自具有1至约4个碳原子的烷基、或具有至多约4个碳原子的烷氧基、聚氧化亚烷基、烷基酰氨基、羟烷基、芳基或烷基芳基基团;并且X-为成盐阴离子,诸如选自卤素(例如氯、溴)、乙酸根、柠檬酸根、乳酸根、乙醇酸根、磷酸根、硝酸根、磺酸根、硫酸根、烷基硫酸根和烷基磺酸根的那些。除了碳原子和氢原子之外,烷基基团还可包含醚键和/或酯键,以及其它基团诸如氨基基团。长链烷基基团例如具有约12个或更多个碳原子的那些可为饱和或不饱和的。优选地,R75、R76、R77和R78中的一者选自具有12至30个碳原子,更优选地16至24个碳原子,还更优选地18至22个碳原子,甚至更优选地22个碳原子的烷基基团;R75、R76、R77和R78中的其余基团独立地选自CH3、C2H5、C2H4OH、以及它们的混合物;并且X选自Cl、Br、CH3OSO3、C2H5OSO3、以及它们的混合物。此类二烷基季铵化铵盐阳离子表面活性剂包括例如二烷基(14-18)二甲基氯化铵、二牛脂烷基二甲基氯化铵、二氢化牛脂烷基二甲基氯化铵、二硬脂基二甲基氯化铵以及双十六烷基二甲基氯化铵。此类二烷基季铵化铵盐阳离子表面活性剂还包括例如不对称的二烷基季铵化铵盐阳离子表面活性剂。
高熔点脂肪族化合物
可用于本文的高熔点脂肪族化合物具有40℃或更高的熔点,并且选自脂肪醇、脂肪酸、脂肪醇衍生物、脂肪酸衍生物、以及它们的混合物。本领域的技术人员应当理解,在说明书的这一部分中公开的化合物在某些情况下可能属于多于一种的类别,例如某些脂肪醇衍生物还可归类为脂肪酸衍生物。然而,给出的分类并不旨在对特定化合物进行限制,而是为了便于分类和命名。此外,本领域的技术人员应当理解根据双键的数目和位置以及支链的长度和位置,具有某些所需碳原子的某些化合物可具有低于25℃的熔点。此类低熔点的化合物不旨在包括在本部分内。高熔点化合物的非限制性示例可见于1993年“International Cosmetic Ingredient Dictionary”第五版;和1992年“CTFA CosmeticIngredient Handbook”第二版。在多种高熔点脂肪族化合物中,优选将脂肪醇用于本发明的组合物中。可用于本文的脂肪醇是具有约14至约30个碳原子,优选地约16至约22个碳原子的那些。这些脂肪醇是饱和的,并且可为直链醇或支链醇。优选的脂肪醇包括例如鲸蜡醇、硬脂醇、二十二醇、以及它们的混合物。
优选高纯度的单一化合物的高熔点脂肪族化合物。选自纯鲸蜡醇、硬脂醇和二十二醇的纯脂肪醇的单一化合物是高度优选的。本文中的“纯”是指化合物具有至少约90%,优选地至少约95%的纯度。当消费者冲洗掉所述组合物时,这些高纯度的单一化合物提供良好的从毛发上的可冲洗性。
为提供改善的调理有益效果,诸如向湿发施用期间的光滑感、柔软性和干发上的润湿感,所述高熔点脂肪族化合物在所述组合物中的含量按所述组合物的重量计为约0.1%至约20%,优选地约1%至约15%,更优选地约1.5%至约8%。
含水载体
本发明的毛发护理组合物的凝胶基质包含含水载体。因此,本发明的制剂可为可倾倒液体的形式(在环境条件下)。因此,此类组合物通常将包含含水载体,所述含水载体的含量为约20重量%至约95重量%,或甚至约60重量%至约85重量%。含水载体可包含水,或水与有机溶剂的可混溶混合物,并且在一个方面可包含水和最小限度的或不显著浓度的有机溶剂,除了另外作为其它组分的微量成分附带地掺入组合物中的那些。
可用于本发明中的含水载体包括水以及低级烷基醇和多元醇的水溶液。可用于本文的低级烷基醇是具有1至6个碳的一元醇,在一个方面,为乙醇和异丙醇。可用于本文的多元醇包括丙二醇、己二醇、甘油、和丙烷二醇。
根据本发明的实施方案,毛发护理组合物在25℃下可具有约2至约10范围内的pH。在一个实施方案中,毛发护理组合物具有约2至约6范围内的pH,这可有助于增溶已经沉积在毛发上的矿物质和氧化还原金属。因此,毛发护理组合物还可有效洗出已存在的矿物和氧化还原金属沉积物,这可降低表皮失真,从而减少表皮破损和损伤。
凝胶基质
本发明的组合物包含凝胶基质。凝胶基质包含阳离子表面活性剂、高熔点脂肪族化合物、以及含水载体。
凝胶基质适于提供各种调理有益效果,诸如向湿发施用期间的光滑感和柔软性以及干发上的润湿感。为提供上述凝胶基质,以一定含量包含阳离子表面活性剂和高熔点脂肪族化合物,使得阳离子表面活性剂与高熔点脂肪族化合物的重量比在优选地约1:1至约1:10,更优选地约1:1至约1:6的范围内。
.附加组分
硅氧烷调理剂
本发明的组合物可包含一种或多种硅氧烷调理剂。硅氧烷的示例包括聚二甲基硅氧烷、聚二甲基硅氧烷醇、环状硅氧烷、甲基苯基聚硅氧烷、和具有各种官能团的改性硅氧烷,所述官能团诸如氨基基团、季铵盐基团、脂族基团、醇基团、羧酸基团、醚基团、糖或多糖基团、氟改性的烷基基团、烷氧基基团、或此类基团的组合。此类硅氧烷可溶于或不溶于含水(或非水)产品载体。在不溶性液体硅氧烷的情况下,聚合物可为具有约10nm至约30微米的液滴尺寸的乳化形式。所述组合物中可存在其它固体或半固体调理剂,包括高熔融温度脂肪醇、酸、酯、酰胺,或不饱和酯、醇、酰胺的低聚物。低聚酯可以是天然存在的不饱和甘油酯的低聚结果。可加入此类固体或半固体调理剂,或可作为与有机油的混合物存在。
非离子聚合物
本发明的毛发护理组合物还可进一步包含非离子聚合物。根据一个实施方案,用于本发明的毛发护理组合物中的调理剂可包含聚亚烷基二醇聚合物。例如,具有大于约1000的分子量的聚亚烷基二醇可用于本文。可用的是具有以下通式(VIII)的那些:
其中R11选自:H、甲基、以及它们的混合物;并且v是乙氧基单元的数目。聚亚烷基二醇诸如聚乙二醇可以约0.001重量%至约10重量%的含量包含于本发明的毛发护理组合物中。在一个实施方案中,聚乙二醇以基于所述组合物的重量计至多约5重量%的量存在。可用于本文的聚乙二醇聚合物为PEG-2M(还被称为PolyoxN-10,其以PEG-2,000购自Union Carbide);PEG-5M(还被称为PolyoxN-35和PolyoxN-80,以PEG-5,000和Polyethylene Glycol 300,000购自Union Carbide);PEG-7M(还被称为PolyoxN-750,购自Union Carbide);PEG-9M(还被称为PolyoxN-3333,购自UnionCarbide);和PEG-14M(还被称为PolyoxN-3000,购自Union Carbide)。
有机调理材料
本发明的组合物的调理剂还可包含单独的或与其它调理剂诸如上述硅氧烷组合的至少一种有机调理材料诸如油或蜡。有机材料可以是非聚合的,低聚的或聚合的。它可为油或蜡的形式,并且可以纯制剂或预乳化形式加入。有机调理材料的一些非限制性示例包括但不限于:i)烃油;ii)聚烯烃,iii)脂肪酸酯,iv)氟化调理化合物,v)脂肪醇,vi)烷基葡糖苷和烷基葡糖苷衍生物;vii)季铵化合物;viii)具有至多约2,000,000分子量的聚乙二醇和聚丙二醇,包括具有CTFA名称PEG-200、PEG-400、PEG-600、PEG-1000、PEG-2M、PEG-7M、PEG-14M、PEG-45M以及它们的混合物的那些。
沉积助剂
本发明的毛发护理组合物还可包含沉积助剂诸如阳离子聚合物。可用于本文的阳离子聚合物是平均分子量为至少约5,000,或约10,000至约1千万,或约100,000至约2百万的那些。
适宜的阳离子聚合物包括例如具有阳离子胺或季铵官能团的乙烯基单体与水溶性间隔单体的共聚物,所述水溶性间隔单体诸如丙烯酰胺、甲基丙烯酰胺、烷基丙烯酰胺和二烷基丙烯酰胺、烷基甲基丙烯酰胺和二烷基甲基丙烯酰胺、丙烯酸烷基酯、甲基丙烯酸烷基酯、乙烯基己内酯和乙烯基吡咯烷酮。其它适宜的间隔单体包括乙烯基酯、乙烯基醇(通过聚乙酸乙烯酯的水解制备)、马来酸酐、丙二醇和乙二醇。可用于本文的其它适宜的阳离子聚合物包括例如阳离子纤维素、阳离子淀粉和阳离子瓜耳胶。
阳离子聚合物可以约0.001重量%至约10重量%的含量包含于本发明的毛发护理组合物中。在一个实施方案中,所述阳离子聚合物以基于所述组合物的重量至多约5重量%的量存在。
有益剂
在一个实施方案中,毛发护理组合物还包含一种或多种附加有益剂。有益剂包括选自以下的材料:去头皮屑剂、抗真菌剂、抗痒剂、抗菌剂、抗微生物剂、保湿剂、抗氧化剂、维生素、脂溶性维生素、螯合剂、香料、增白剂、酶、感觉剂、诱虫剂、染料、颜料、漂白剂、以及它们的混合物。
在一个方面,所述有益剂可包含去头皮屑剂。此类去头皮屑微粒应该在物理和化学上与组合物的组分相容,并且不应该不适当以其他方式地破坏产品的稳定性、美观性或性能。
根据一个实施方案,毛发护理组合物包含去头皮屑活性物质,其可为去头皮屑活性物质微粒。在一个实施方案中,去头皮屑活性物质选自:吡啶硫酮盐;唑类,诸如酮康唑、益康唑和新康唑;硫化硒;微粒硫;角质层分离剂诸如水杨酸;以及它们的混合物。在一个实施方案中,去头皮屑微粒为吡啶硫酮盐。
吡啶硫酮微粒是合适的微粒去头皮屑活性物质。在一个实施方案中,去头皮屑活性物质为1-羟基-2-吡啶硫酮盐,并且为微粒形式。在一个实施方案中,吡啶硫酮去头皮屑微粒的浓度在约0.01重量%至约5重量%,或约0.1重量%至约3重量%,或约0.1重量%至约2重量%范围内。在一个实施方案中,吡啶硫酮盐是由重金属诸如锌、锡、镉、镁、铝和锆(一般为锌)形成的那些,通常为1-羟基-2-吡啶硫酮的锌盐(称为“吡啶硫酮锌”或“ZPT”),通常为片状颗粒形式的1-羟基-2-吡啶硫酮盐。在一个实施方案中,片状颗粒形式的1-羟基-2-吡啶硫酮盐具有至多约20微米,或至多约5微米,或至多约2.5微米的平均粒度。由其它阳离子诸如钠形成的盐也可为适宜的。吡啶硫酮去头皮屑活性物质描述于例如美国专利2,809,971;美国专利3,236,733;美国专利3,753,196;美国专利3,761,418;美国专利4,345,080;美国专利4,323,683;美国专利4,379,753;和美国专利4,470,982中。
在一个实施方案中,除了选自巯基吡啶氧化物的多价金属盐的去头皮屑活性物质以外,所述组合物还包含一种或多种抗真菌和/或抗微生物活性物质。在一个实施方案中,抗微生物活性物质选自:煤焦油、硫、fcharcoal、复方苯甲酸软膏、卡斯太拉尼氏涂剂、氯化铝、龙胆紫、羟甲辛吡酮(羟甲辛吡酮乙醇胺)、环吡酮胺、十一碳烯酸及其金属盐、高锰酸钾、硫化硒、硫代硫酸钠、丙二醇、苦橙油、脲制剂、灰黄霉素、8-羟基喹啉氯碘羟喹、硫代苄苯咪唑(thiobendazole)、硫代氨基甲酸酯、卤普罗近、聚烯、羟基吡啶酮、吗啉、苄胺、烯丙胺(诸如特比萘芬)、茶树油、丁香叶油、芫荽、玫瑰草、小檗碱、百里香红、桂皮油、肉桂醛、香茅酸、扁柏酚、鱼石脂白、Sensiva SC-50、Elestab HP-100、壬二酸、溶细胞酶、碘代丙炔基丁基氨基甲酸盐(IPBC)、异噻唑啉酮诸如辛基异噻唑啉酮、和唑类、以及它们的混合物。在一个实施方案中,抗微生物剂选自:伊曲康唑、酮康唑、硫化硒、煤焦油、以及它们的混合物。
在一个实施方案中,唑类抗微生物剂为咪唑,其选自:苯并咪唑、苯并噻唑、联苯苄唑、丁康唑硝酸盐、咪菌酮、克霉唑、克鲁康唑、依柏康唑、益康唑、新康唑、芬替康唑、氟康唑、氟三唑、异康唑、酮康唑、兰诺康唑、甲硝唑、咪康唑、奈康唑、奥莫康唑、硝酸奥昔康唑、舍他康唑、硝酸硫康唑、噻康唑、噻唑、以及它们的混合物,或唑类抗微生物剂为三唑,其选自:特康唑、伊曲康唑、以及它们的混合物。当存在于毛发护理组合物中时,唑类抗微生物活性物质的含量为约0.01重量%至约5重量%,或约0.1重量%至约3重量%,或约0.3重量%至约2重量%。在一个实施方案中,唑类抗微生物活性物质为酮康唑。在一个实施方案中,唯一的抗微生物活性物质为酮康唑。
毛发护理组合物的实施方案还可包含抗微生物活性物质的组合。在一个实施方案中,抗微生物活性物质的组合选自由以下组成的组合:羟甲辛吡酮和吡啶硫酮锌、松树焦油和硫、水杨酸和吡啶硫酮锌、水杨酸和新康唑、吡啶硫酮锌和新康唑、吡啶硫酮锌和咪菌酮、羟甲辛吡酮和咪菌酮、水杨酸和羟甲辛吡酮、以及它们的混合物。
在一个实施方案中,所述组合物包含有效量的含锌层状物质。在一个实施方案中,所述组合物包含按所述组合物的总重量计约0.001重量%至约10重量%,或约0.01重量%至约7重量%,或约0.1重量%至约5重量%的含锌层状物质。
含锌层状物质可为主要在二维平面上具有晶体生长的那些。常规上将层状结构描述为其中不仅所有原子均掺入到良好限定的层中,而且其中在层间存在称为隧道离子(A.F.Wells,“Structural Inorganic Chemistry”,Clarendon Press,1975)的离子或分子的那些。含锌层状物质(ZLM)可具有掺入到层中的锌和/或可作为隧道离子的组分。下列类别的ZLM代表了总类别中较常见的示例,并且不旨在对范围更广的符合此定义的材料作出限制。
许多ZLM在自然界以矿物的形式出现。在一个实施方案中,ZLM选自:水锌矿(碳酸锌氢氧化物)、绿铜锌矿(碳酸锌铜氢氧化物)、斜方绿铜锌矿(碳酸铜锌氢氧化物)、以及它们的混合物。相关的含锌矿物也可包含于组合物中。天然ZLM也可存在,其中阴离子层物质诸如粘土型矿物质(如页硅酸盐)包含离子交换的锌隧道离子。所有这些天然物质也可通过合成获得,或在组合物中或在生产过程期间原位形成。
另一种通常但不总是合成获得的常见类别ZLM为层状二元氢氧化物。在一个实施方案中,ZLM为符合式[M2+ 1-xM3+ x(OH)2]x+Am- x/m·nH2O的层状二元氢氧化物,其中一些或所有的二价离子(M2+)为锌离子(Crepaldi,EL,Pava,PC,Tronto,J,Valim,JB J.ColloidInterfac.Sci.2002,248,429-42)。
可制备另一类别的ZLM,称为羟基复盐(Morioka,H.,Tagaya,H.,Karasu,M,Kadokawa,J,Chiba,KInorg.Chem.1999,38,4211-6)。在一个实施方案中,ZLM为符合式[M2 + 1-xM2+ 1+x(OH)3(1-y)]+An -(1=3y)/n·nH2O的羟基复盐,其中两个金属离子(M2+)可相同或不同。如果它们相同并且由锌表示,则所示式简化为[Zn1+x(OH)2]2x+2x A-·nH2O。后一式代表了(其中x=0.4)材料诸如羟基氯化锌和碱式硝酸锌。在一个实施方案中,ZLM为羟基氯化锌和/或碱式硝酸锌。这些也涉及水锌矿,其中二价阴离子替换了一价阴离子。这些材料还可在组合物中或在生产过程中或生产过程期间原位形成。
在具有含锌层状物质和巯基吡啶氧化物或巯基吡啶氧化物的多价金属盐的实施方案中,含锌层状物质与巯基吡啶氧化物或巯基吡啶氧化物的多价金属盐的比率为约5:100至约10:1,或约2:10至约5:1,或约1:2至约3:1。
去头皮屑活性物质的头皮上沉积物为至少约1μg/cm2。为确保去头皮屑活性物质到达它能够执行其功能的头皮,去头皮屑活性物质的头皮上沉积物是重要的。在一个实施方案中,去头皮屑活性物质在头皮上的沉积物为至少约1.5μg/cm2,或至少约2.5μg/cm2,或至少约3μg/cm2,或至少约4μg/cm2,或至少约6μg/cm2,或至少约7μg/cm2,或至少约8μg/cm2,或至少约8μg/cm2,或至少约10μg/cm2。根据常规洗涤方案,由专业美容师用包含去头皮屑活性物质的组合物例如根据本发明的组合物洗涤个体毛发,来测量去头皮屑活性物质的头皮上沉积。然后头皮区域上的毛发分开,以使末端开放的玻璃量筒能够保留在表面上,同时添加提取溶液的等分试样,并且搅拌,然后回收,并且由常规方法诸如HPLC分析测定去头皮屑活性物质含量。
载体
本发明的组合物可包含含水载体。根据与其它组分的相容性和产品的其它所需特性来选择所述载体的含量和种类。
可用于本发明的载体包括水和低级烷基醇的水溶液。可用于本文的低级烷基醇是具有1至6个碳的一元醇,并且在另一个实施方案中为乙醇和异丙醇。
在本发明的实施方案中,含水载体基本上为水。在另一个实施方案中,可使用去离子水。根据产品的所需特性,还可使用包含矿物阳离子的来自天然来源的水。一般来讲,本发明的组合物包含约0%至约99%,在一个实施方案中约50%至约95%,在另一个实施方案中约70%至约90%,并且在另一个实施方案中约80%至约90%的水。
流变改性剂/悬浮剂
在一个实施方案中,洗去型调理剂组合物包含流变改性剂。流变改性剂增加了所述组合物的亲和性和稳定性,改善了感觉和消费者的使用经验(例如无滴落、铺展性等)。可使用任何合适的流变改性剂。在一个实施方案中,毛发护理组合物可包含约0.05%至约10%的流变改性剂,在另一个实施方案中约0.1%至约10%的流变改性剂,在另一个实施方案中约0.5%至约2%的流变改性剂,在另一个实施方案中约0.7%至约2%的流变改性剂,以及在另一个实施方案中约1%至约1.5%的流变改性剂。在一个实施方案中,流变改性剂可为聚丙烯酰胺增稠剂。在一个实施方案中,流变改性剂可以为聚合物流变改性剂。
在一个实施方案中,洗去型调理剂组合物可包含流变改性剂,该流变改性剂为基于丙烯酸、甲基丙烯酸或其它相关衍生物的均聚物,非限制性示例包括聚丙烯酸酯、聚甲基丙烯酸酯、聚丙烯酸乙酯、和聚丙烯酰胺。
在另一个实施方案中,流变改性剂可为碱性可溶胀和疏水改性的碱性可溶胀丙烯酸共聚物或甲基丙烯酸共聚物,非限制性示例包括丙烯酸/丙烯腈(acrylonitrogen)共聚物、丙烯酸酯/硬脂基聚氧乙烯醚-20衣康酸酯共聚物、丙烯酸酯/十六烷基聚氧乙烯醚-20衣康酸酯共聚物、丙烯酸酯/氨基丙烯酸酯共聚物、丙烯酸酯/硬脂基聚氧乙烯醚-20甲基丙烯酸酯共聚物、丙烯酸酯/山嵛醇聚醚-25甲基丙烯酸酯共聚物、丙烯酸酯/硬脂基聚氧乙烯醚-20甲基丙烯酸酯交联聚合物、丙烯酸酯/乙烯基新癸酸酯交联聚合物、以及丙烯酸酯/C10-C30烷基丙烯酸酯交联聚合物。
在另一个实施方案中,流变改性剂可为交联丙烯酸聚合物,非限制性示例包括卡波姆。
在另一个实施方案中,流变改性剂可为基于藻酸的材料;非限制性示例包括藻酸钠和藻酸丙二醇酯。
在另一个实施方案中,流变改性剂可为缔合聚合物增稠剂,非限制性示例包括:疏水改性的纤维素衍生物;疏水改性的烷氧基化尿烷聚合物,非限制性示例包括PEG-150/癸醇/SMDI共聚物、PEG-150/硬脂醇/SMDI共聚物、聚氨酯-39;疏水改性的碱性可溶胀乳液,非限制性示例包括疏水改性的聚丙烯酸酯、疏水改性的聚丙烯酸、以及疏水改性的聚丙烯酰胺;疏水改性的聚醚,其中这些材料可具有可选自鲸蜡基、硬脂基、油酰基以及它们的组合的疏水部分,以及具有10-300,在另一个实施方案中30-200,在另一个实施方案中40-150个重复单元的重复氧化亚乙基基团的亲水部分。该类型的非限制性示例包括PEG-120-甲基葡萄糖二油酸酯、PEG-(40或60)脱水山梨糖醇四油酸酯、PEG-150季戊四醇四硬脂酸酯、PEG-55丙二醇油酸酯、PEG-150二硬脂酸酯。
在另一个实施方案中,流变改性剂可为纤维素和衍生物;非限制性示例包括微晶纤维素、羧甲基纤维素、羟乙基纤维素、羟丙基纤维素、羟丙基甲基纤维素、甲基纤维素、乙基纤维素、硝酸纤维素、硫酸纤维素、纤维素粉末以及疏水改性的纤维素。
在一个实施方案中,流变改性剂可为瓜尔胶和瓜尔胶衍生物;非限制性示例包括羟丙基瓜尔胶、以及羟丙基瓜尔胶羟丙基三甲基氯化铵。
在一个实施方案中,流变改性剂可为聚环氧乙烷、聚环氧丙烷、以及POE-PPO共聚物。
在一个实施方案中,流变改性剂可为聚乙烯吡咯烷酮、交联聚乙烯吡咯烷酮以及衍生物。在另一个实施方案中,流变改性剂可为聚乙烯醇以及衍生物。
在另一个实施方案中,流变改性剂可为聚乙烯亚胺以及衍生物。
在另一个实施方案中,流变改性剂可为二氧化硅;非限制性示例包括热解法二氧化硅、沉淀二氧化硅和硅氧烷-表面处理的二氧化硅。
在一个实施方案中,流变改性剂可为水溶胀性粘土;非限制性示例包括合成锂皂石、膨润土、蒙脱土、蒙皂石和锂蒙脱石。
在一个实施方案中,流变改性剂可为树胶,非限制性示例包括黄原胶、瓜尔胶、羟丙基瓜尔胶、阿拉伯胶、黄蓍胶、半乳聚糖、长豆角胶、刺梧桐树胶和刺槐豆胶。
在另一个实施方案中,流变改性剂可为二亚苄基山梨醇、karaggenan、果胶、琼脂、温柏树籽(榅桲子(Cydonia oblonga Mill))、淀粉(得自稻、玉米、马铃薯、小麦等)、淀粉衍生物(例如羧甲基淀粉、甲基羟丙基淀粉)、藻类提取物、葡聚糖、琥珀酰葡聚糖(succinoglucan)以及pulleran。
在一个实施方案中,本发明的组合物可包含悬浮剂,所述悬浮剂包括可分类为酰基衍生物、长链氧化胺以及它们的混合物的结晶悬浮剂。这些悬浮剂描述于美国专利4,741,855中。这些悬浮剂包括在一个方面具有约16至约22个碳原子的脂肪酸的乙二醇酯。在一个方面,可用的悬浮剂包括硬脂酸乙二醇酯,一硬脂酸酯和二硬脂酸酯两者,但在一个方面,二硬脂酸酯包含小于约7%的一硬脂酸酯。其它合适的悬浮剂包括具有约16至约22个碳原子,或甚至约16至18个碳原子的脂肪酸的烷醇酰胺,其示例包括硬脂酰一乙醇胺、硬脂酰二乙醇胺、硬脂酰一异丙醇胺和硬脂酰一乙醇胺硬脂酸酯。除了上文所列的材料以外,其它长链酰基衍生物可用作悬浮剂,包括长链脂肪酸的长链酯(如硬脂酸十八烷基酯、棕榈酸鲸蜡酯等);长链烷醇酰胺的长链酯(如硬脂酰胺二乙醇酰胺二硬脂酸酯、硬脂酰胺单乙醇酰胺硬脂酸酯);和甘油酯(如甘油二硬脂酸酯、三羟基硬脂酸甘油酯、三山嵛酸甘油酯),其商业示例为购自Rheox,Inc.的Thixin R;长链酰基衍生物、长链羧酸的乙二醇酯、长链氧化胺和长链羧酸的烷醇酰胺。适用作悬浮剂的其它长链酰基衍生物包括N,N-二烃基酰氨基苯甲酸及其可溶性盐(例如Na、K),尤其是该类中的N,N-二(氢化)C16、C18和牛脂酰氨基苯甲酸类,其可从Stepan Company(Northfield,Ill.,USA)商购获得。适用作悬浮剂的长链氧化胺的示例包括烷基二甲基氧化胺,如硬脂基二甲基氧化胺。其它适宜的悬浮剂包括具有含至少约16个碳原子的脂肪烷基部分的伯胺(其示例包括棕榈胺或十八胺)和具有两个各含至少约12个碳原子的脂肪烷基部分的仲胺(其示例包括二棕榈酰基胺或二(氢化牛脂)胺)。其它合适的悬浮剂包括二(氢化牛脂)邻苯二甲酸酰胺和交联的马来酸酐-甲基乙烯基醚共聚物。
流变改性剂的非限制性示例包括丙烯酰胺/丙烯酸铵共聚物(和)聚异丁烯(和)聚山梨酸酯20;丙烯酰胺/丙烯酰二甲基牛磺酸钠共聚物/异十六烷/聚山梨酸酯80;丙烯酸酯共聚物;丙烯酸酯/山嵛醇聚醚-25甲基丙烯酸酯共聚物;丙烯酸酯/C10-C30烷基丙烯酸酯交联聚合物;丙烯酸酯/硬脂基聚氧乙烯醚-20衣康酸酯共聚物;聚丙烯酸铵/异十六烷/PEG-40蓖麻油;C12-16烷基PEG-2羟丙基羟乙基乙基纤维素(HM-EHEC);卡波姆;交联聚乙烯吡咯烷酮(PVP);二亚苄基山梨醇;羟乙基乙基纤维素(EHEC);羟丙基甲基纤维素(HPMC);羟丙基甲基纤维素(HPMC);羟丙基纤维素(HPC);甲基纤维素(MC);甲基羟乙基纤维素(MEHEC);PEG-150/癸醇/SMDI共聚物;PEG-150/硬脂醇/SMDI共聚物;聚丙烯酰胺/C13-14异链烷烃/月桂基聚氧乙烯醚-7;聚丙烯酸酯13/聚异丁烯/聚山梨酸酯20;聚丙烯酸酯交联聚合物-6;聚酰胺-3;聚季铵盐-37(和)氢化聚癸烯(和)十三烷基聚氧乙烯醚-6;聚氨酯-39;丙烯酸钠/丙烯酰二甲基牛磺酸酯/二甲基丙烯酰胺;交联聚合物(和)异十六烷(和)聚山梨酸酯60;聚丙烯酸钠。示例性的可商购获得的流变改性剂包括ACULYNTM28,KlucelTMM CS,KlucelTMH CS,KlucelTMG CS,SYLVACLEARTMAF1900V,SYLVACLEARTMPA1200V,BenecelTME10M,BenecelTMK35M,OptasenseTMRMC70,ACULYNTM33,ACULYNTM46,ACULYNTM22,ACULYNTM44,Carbopol UltrezTM20,Carbopol UltrezTM21,Carbopol UltrezTM10,CarbopolUlterezTM30,CarbopolTM1342,CarbopolTM934,CarbopolTM940,CarbopolTM950,CarbopolTM980,以及CarbopolTM981,AcrysolTM22,SepigelTM305,SimulgelTM600,SepimaxZen、以及它们的组合。
还注意本文未使用类似“另选地”、“常常”、“一般”、“通常”和“典型地”的术语来限制受权利要求书保护的发明的范围或暗示某些特征对于受权利要求书保护的发明的结构或功能是关键、必需或甚至重要的。相反,这些术语仅仅旨在突出可在或可不在本发明的特定实施方案中利用的可供选择的特征或附加特征。
为了描述和限定本发明,另外注意到本文使用术语“基本上”来表示可表征任何定量的比较、值、测量、或其它表示的固有的不确定度。术语“基本上”在本文中也可用来表示定量表示可相对于所声明的参考发生变化而不会导致所关注的主题的基本功能发生变化的程度。
虽然已经详细地并且参考其具体的实施方案描述了本发明,但是将显而易见的是在不脱离所附权利要求限定的本发明范围的情况下各种修改和变型是可能的。更具体地讲,尽管本发明的一些方面在本文中被识别为优选的或特别有利的,但预期本发明不必局限于本发明的这些优选的方面。
在本发明的具体实施方式中引用的所有文件都在相关部分中以引用方式并入本文中;对于任何文件的引用不应当解释为承认其是有关本发明的现有技术。当本书面文件中术语的任何含义或定义与以引用方式并入的文件中术语的任何含义或定义矛盾时,应当服从在本书面文件中赋予该术语的含义或定义。
Claims (20)
1.一种用于减少毛发卷曲的洗去型调理剂组合物,所述洗去型调理剂组合物包含:
0.2%至20%的水分控制材料或水分控制材料的混合物,其中所述水分控制材料包含水杨酸与2,4-二羟基苯甲酸的组合,并且其中所述洗去型调理剂组合物还包含选自以下的材料:二醇、聚二醇、2-羟乙基脲和它们的混合物。
2.根据权利要求1所述的洗去型调理剂组合物,其中所述水分控制材料的浓度或所述水分控制材料的混合物的浓度是0.5%至8%。
3.根据权利要求1所述的洗去型调理剂组合物,其中所述水分控制材料的浓度或所述水分控制材料的混合物的浓度是0.5%至5%。
4.根据权利要求1所述的洗去型调理剂组合物,其中相对于不含所述水分控制材料的对照组合物,存在15%的卷曲减少。
5.根据权利要求1所述的洗去型调理剂组合物,其中相对于不含所述水分控制材料的对照组合物,存在20%的卷曲减少。
6.根据权利要求1所述的洗去型调理剂组合物,其中所述水分控制材料还包含5-氯水杨酸。
7.根据权利要求1所述的洗去型调理剂组合物,其中所述洗去型调理剂组合物还包含5-氯水杨酸和丙二醇的组合。
8.根据权利要求1所述的洗去型调理剂组合物,所述洗去型调理剂组合物还包含5-氯水杨酸和硅氧烷的组合。
9.根据权利要求1所述的洗去型调理剂组合物,所述洗去型调理剂组合物包含0.5%至2%的水杨酸与0.2%至10%的2-羟乙基脲的组合。
10.根据权利要求1所述的洗去型调理剂组合物,其中所述洗去型调理剂组合物的pH在2至7的范围内。
11.根据权利要求1所述的洗去型调理剂组合物,其中所述洗去型调理剂组合物的pH在2至5的范围内。
12.根据权利要求1所述的洗去型调理剂组合物,其中所述洗去型调理剂组合物还包含硅氧烷。
13.根据权利要求1所述的洗去型调理剂组合物,其中所述洗去型调理剂组合物还包含选自以下的材料:溶剂、流变改性剂、悬浮剂、颜料、研磨剂、生物活性物质、螯合试剂、pH调节剂、染料以及它们的混合物。
14.根据权利要求1所述的洗去型调理剂组合物,其中所述洗去型调理剂组合物还包含选自以下的材料:调理材料、毛发健康活性物质以及它们的混合物。
15.根据权利要求1所述的洗去型调理剂组合物,其中所述洗去型调理剂组合物还包含选自以下的材料:去头皮屑活性物质、抗氧化剂、抗菌剂、维生素、香料、增白剂、漂白剂、增稠剂、缓冲剂以及它们的混合物。
16.根据权利要求14所述的洗去型调理剂组合物,其中所述调理材料是有机调理材料。
17.根据权利要求13所述的洗去型调理剂组合物,其中所述生物活性物质是酶。
18.根据权利要求1所述的洗去型调理剂组合物,其中所述洗去型调理剂组合物还包含阳离子表面活性剂体系。
19.根据权利要求1所述的洗去型调理剂组合物,其中所述洗去型调理剂组合物还包含:
i.按所述洗去型调理剂组合物的重量计0.1%至20%的一种或多种高熔点脂肪族化合物;
ii.按所述洗去型调理剂组合物的重量计0.1%至10%的阳离子表面活性剂体系;和
iii.按所述洗去型调理剂组合物的重量计至少20%的含水载体。
20.一种用于减少毛发卷曲的洗去型调理剂组合物,所述洗去型调理剂组合物包含:0.2%至20%的水分控制材料或水分控制材料的混合物,其中,所述水分控制材料是水杨酸与2,4-二羟基苯甲酸的组合,并且进一步地,其中,与不含所述水分控制材料的对照组合物相比,存在至少4%的卷曲减少。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462088029P | 2014-12-05 | 2014-12-05 | |
US62/088,029 | 2014-12-05 | ||
PCT/US2015/063888 WO2016090206A1 (en) | 2014-12-05 | 2015-12-04 | Composition for hair frizz reduction |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107106437A CN107106437A (zh) | 2017-08-29 |
CN107106437B true CN107106437B (zh) | 2020-12-04 |
Family
ID=55022707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201580066199.0A Active CN107106437B (zh) | 2014-12-05 | 2015-12-04 | 用于减少毛发卷曲的组合物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US10117819B2 (zh) |
EP (1) | EP3226833B1 (zh) |
JP (1) | JP6412270B2 (zh) |
CN (1) | CN107106437B (zh) |
MX (1) | MX369683B (zh) |
WO (1) | WO2016090206A1 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10111815B2 (en) | 2014-06-17 | 2018-10-30 | The Procter And Gamble Company | Composition for hair frizz reduction |
JP6412270B2 (ja) | 2014-12-05 | 2018-10-24 | ザ プロクター アンド ギャンブル カンパニー | 縮毛を減少させるための組成物 |
US10632054B2 (en) | 2015-04-02 | 2020-04-28 | The Procter And Gamble Company | Method for hair frizz reduction |
US10660835B2 (en) | 2015-04-02 | 2020-05-26 | The Procter And Gamble Company | Method for hair frizz reduction |
WO2017096156A1 (en) * | 2015-12-04 | 2017-06-08 | The Procter & Gamble Company | Composition for hair frizz reduction |
US10561591B2 (en) | 2015-12-04 | 2020-02-18 | The Procter And Gamble Company | Hair care regimen using compositions comprising moisture control materials |
US10406094B2 (en) | 2016-04-01 | 2019-09-10 | The Procter And Gamble Company | Composition for fast dry of hair |
GB201703674D0 (en) * | 2017-03-08 | 2017-04-19 | Givaudan Sa | Chemical composition |
US10980723B2 (en) | 2017-04-10 | 2021-04-20 | The Procter And Gamble Company | Non-aqueous composition for hair frizz reduction |
MX2020004030A (es) | 2017-10-20 | 2020-08-13 | Unilever Ip Holdings B V | Composicion para el tratamiento del cabello. |
US11229592B2 (en) | 2017-10-20 | 2022-01-25 | Conopco, Inc. | Method for hair volume reduction |
MX2021004798A (es) | 2018-10-31 | 2021-06-08 | Unilever Ip Holdings B V | Composicion para tratamiento del cabello. |
US12128126B2 (en) | 2018-10-31 | 2024-10-29 | Conopco, Inc. | Hair treatment composition |
US11883513B2 (en) | 2019-12-10 | 2024-01-30 | The Procter & Gamble Company | Hair strengthening composition |
US20220387278A1 (en) * | 2019-12-30 | 2022-12-08 | L'oreal | Anhydrous composition for caring for keratin materials |
BR112023020355A2 (pt) | 2021-04-15 | 2023-11-21 | Unilever Ip Holdings B V | Método de fornecimento de antifrizz para cabelo e uso de uma composição |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3541485A1 (de) * | 1985-11-23 | 1987-05-27 | Wella Ag | Verfahren zur behandlung von menschlichen haaren mit alkalischen haarbehandlungsmitteln |
JPS62132813A (ja) * | 1985-12-05 | 1987-06-16 | Sanshidou Seiyaku Kk | 毛髪処理用薬剤及び毛髪処理方法 |
JP2004210724A (ja) * | 2002-12-27 | 2004-07-29 | Lion Corp | 毛髪化粧料 |
Family Cites Families (105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2392314A (en) | 1943-03-02 | 1946-01-08 | Corning Glass Company | Glass-to-metal seal |
NL102645C (zh) | 1954-11-12 | |||
DE3201511A1 (de) | 1982-01-20 | 1983-07-28 | Henkel Kgaa | Sebosuppressive kosmetische mittel, welche laengerkettige alkanole und antioxidantien enthalten |
US4678475A (en) | 1986-01-21 | 1987-07-07 | Helene Curtis, Inc. | Dye-conditioner composition that is non-staining to skin containing a certified violet dye and a quaternary ammonium compound |
JPH0774135B2 (ja) | 1986-12-19 | 1995-08-09 | ライオン株式会社 | 毛髪化粧料 |
DE69009223T2 (de) | 1989-02-23 | 1995-01-12 | Kao Corp | Haarbehandlungsmittel. |
JP3009959B2 (ja) | 1992-01-27 | 2000-02-14 | 鐘紡株式会社 | ヘアーリンス組成物 |
FI930458A7 (fi) | 1992-03-27 | 1993-09-28 | Curtis Helene Ind Inc | Opasiteettia lisäävä aine vesipohjaisia koostumuksia varten |
JP3229689B2 (ja) | 1992-07-21 | 2001-11-19 | 花王株式会社 | 毛髪化粧料 |
MX9305745A (es) * | 1992-09-22 | 1994-05-31 | Colgate Palmolive Co | Champu o tratamiento de control de estilo acondicionador del cabello. |
JPH06256137A (ja) | 1993-03-01 | 1994-09-13 | Chugai Pharmaceut Co Ltd | 美白用皮膚外用剤 |
US6001340A (en) | 1993-03-30 | 1999-12-14 | Steven E. Rosen | Topical compositions and methods for treating Pseudofolliculitis barbae and ingrown hair |
US5688495A (en) | 1993-03-30 | 1997-11-18 | Rosen; Steven E. | Topical deodorant compositions |
JP3190792B2 (ja) | 1994-09-29 | 2001-07-23 | 花王株式会社 | 毛髪変形剤組成物 |
KR20010013377A (ko) | 1997-06-04 | 2001-02-26 | 데이비드 엠 모이어 | 마일드한 잔류성 항균 조성물 |
JP3026213B2 (ja) | 1997-12-08 | 2000-03-27 | 花王株式会社 | 毛髪化粧料 |
TWI222872B (en) * | 1997-12-08 | 2004-11-01 | Kao Corp | Cuticle caring method, hair volume enhancing method and hair cosmetic composition |
US20040180016A1 (en) | 1998-02-13 | 2004-09-16 | Buck Carol J. | Formulations and methods for straightening hair |
US6517822B1 (en) | 1998-02-13 | 2003-02-11 | Carol J. Buck | Formulations and methods for straightening hair |
US6495498B2 (en) | 1999-05-27 | 2002-12-17 | Johnson & Johnson Consumer Companies, Inc. | Detergent compositions with enhanced depositing, conditioning and softness capabilities |
AU1095801A (en) * | 1999-10-19 | 2001-04-30 | Procter & Gamble Company, The | Antimicrobial compositions comprising a biologically active organic acid |
JP2001122737A (ja) | 1999-10-27 | 2001-05-08 | Kose Corp | ヘアコンディショニング組成物 |
DE10051774A1 (de) | 2000-10-19 | 2002-04-25 | Henkel Kgaa | Neue Verwendung von kurzkettigen Carbonsäuren |
DE10126252A1 (de) | 2001-05-29 | 2002-12-05 | Clariant Gmbh | Neiartig konfektionierte quaternäre Ammoniumverbindungen |
DE10155542A1 (de) | 2001-11-12 | 2003-05-22 | Basf Ag | Kosmetische oder dermatologische Lichtschutzmittelzubereitung |
DE10163052A1 (de) | 2001-12-21 | 2003-07-17 | Henkel Kgaa | Restrukturierung und Ausrüstung keratinischer Fasern |
WO2003096996A1 (en) * | 2002-05-15 | 2003-11-27 | Unilever N.V. | Hair care compositions containing phenolic styling agents |
AU2003273285B2 (en) | 2002-06-04 | 2007-01-25 | The Procter & Gamble Company | Shampoo containing a gel network |
JP3843051B2 (ja) | 2002-08-09 | 2006-11-08 | 花王株式会社 | シャンプー組成物 |
US7939489B2 (en) | 2002-12-23 | 2011-05-10 | Avon Products, Inc. | Oil absorbent topical compositions and methods for using same |
JP2004269430A (ja) | 2003-03-10 | 2004-09-30 | Ichimaru Pharcos Co Ltd | 毛髪処理用組成物及び損傷毛用毛髪化粧料 |
FR2857257B1 (fr) | 2003-07-07 | 2007-10-19 | Oreal | Utilisation de derives cellulosiques modifies en tant qu'agent epaississant de la phase organique d'une composition de vernis a ongles. |
TWI347195B (en) | 2003-08-01 | 2011-08-21 | Kao Corp | Method of treating hair and hair quality improving cosmetic set |
US20050143268A1 (en) | 2003-11-14 | 2005-06-30 | The Procter & Gamble Company | Personal care composition containing a cleansing phase and a benefit phase |
JP2005145883A (ja) | 2003-11-14 | 2005-06-09 | Ichimaru Pharcos Co Ltd | 化粧料組成物 |
US8399001B2 (en) | 2003-11-18 | 2013-03-19 | L'oreal | Cosmetic composition comprising at least one gellan gum or derivative thereof, at least one monovalent salt, and at least one suspension compound, processes using this composition, and uses thereof |
JP2005194261A (ja) | 2003-12-10 | 2005-07-21 | Lion Corp | ちぢれ毛矯正剤 |
US20050136015A1 (en) | 2003-12-17 | 2005-06-23 | McKie Derrick B. | Topical use of halosalicylic acid derivatives |
JP4329097B2 (ja) | 2004-01-28 | 2009-09-09 | 山栄化学株式会社 | O/w型クリーム状毛髪仕上げ剤 |
JP4452523B2 (ja) | 2004-02-27 | 2010-04-21 | 花王株式会社 | 毛髪化粧料 |
JP4324494B2 (ja) | 2004-02-27 | 2009-09-02 | 花王株式会社 | 毛髪化粧料 |
US20050266034A1 (en) | 2004-05-10 | 2005-12-01 | Rainer Muller | Cosmetic and/or dermatological composition based on at least one surfactant, at least one monocarboxylic acid, and at least one polyol |
MX2007006860A (es) | 2004-12-09 | 2008-02-15 | Dial Corp | Composiciones que tienen alta eficacia antiviral y antibacterial. |
JP4679893B2 (ja) | 2004-12-13 | 2011-05-11 | ライオン株式会社 | グリーンノートを有する香料を含有する化粧料 |
US20060204466A1 (en) | 2005-03-08 | 2006-09-14 | Ecolab Inc. | Hydroalcoholic antimicrobial composition with skin health benefits |
JP4625357B2 (ja) | 2005-03-31 | 2011-02-02 | 株式会社コーセー | 毛髪化粧料 |
WO2006137004A2 (en) | 2005-06-21 | 2006-12-28 | The Procter & Gamble Company | Hair conditioning composition comprising gel matrix and high molecular weight water-soluble cationic polymer |
JP4883261B2 (ja) | 2005-06-27 | 2012-02-22 | ライオン株式会社 | 毛髪化粧料 |
JP2007070469A (ja) | 2005-09-07 | 2007-03-22 | Lion Corp | 洗浄剤組成物 |
EP1767613A1 (en) | 2005-09-23 | 2007-03-28 | Takasago International Corporation | Process for the manufacture of a spray dried powder |
FR2891742A1 (fr) | 2005-10-07 | 2007-04-13 | Oreal | Compostion cosmetique a base de monomeres electrophiles et d'une dispersion de particules de polymere stabilisees en surface |
JP5086539B2 (ja) | 2005-12-27 | 2012-11-28 | ライオン株式会社 | 毛髪化粧料 |
FR2899811B1 (fr) | 2006-04-13 | 2008-07-04 | Oreal | Utilisation d'une composition cosmetique comprenant au moins un monomere cyanocrylate polymerisable et au moins un agent de conditionnement pour ameliorer la couleur de fibres keratiniques teintes artificiellement |
FR2901470B1 (fr) | 2006-05-24 | 2010-06-04 | Oreal | Procede de defrisage des fibres keratimiques avec un moyen de chauffage et un compose aromatique |
FR2907002B1 (fr) | 2006-10-13 | 2009-03-06 | Oreal | Procede de coloration au moyen d'un colorant de type styrylique ou iminique en combinaison avec un acide faible et dispositif pour la mise en oeuvre du procede |
JP2008184423A (ja) | 2007-01-30 | 2008-08-14 | Kao Corp | 毛髪うねり改善剤 |
CA2675259A1 (en) | 2007-02-09 | 2008-08-21 | The Procter & Gamble Company | Perfume systems |
JP5228338B2 (ja) | 2007-02-27 | 2013-07-03 | ライオン株式会社 | 毛髪洗浄剤 |
FR2920966B1 (fr) | 2007-09-14 | 2010-03-19 | Oreal | Procede capillaire comprenant l'application d'une polyamine et d'un acide gras |
WO2009053163A1 (en) | 2007-10-25 | 2009-04-30 | Unilever Plc | Hair care composition |
US20090169502A1 (en) | 2008-01-02 | 2009-07-02 | L'oreal | Compositions and methods for treating keratinous substrates using polyamides |
MX2010008287A (es) | 2008-02-01 | 2010-08-31 | Amcol International Corp | Composicion mejorada, aclaradora de la piel. |
FR2931659B1 (fr) | 2008-06-02 | 2011-03-04 | Oreal | Procede de prevention de l'apparition de mauvaises odeurs lors d'un procede de deformation permanente des cheveux |
CN102215807A (zh) | 2008-06-25 | 2011-10-12 | 宝洁公司 | 包含二十二烷基三甲基氯化铵并具有较高屈服点的毛发调理组合物 |
EP2392314B1 (en) | 2009-01-30 | 2019-08-14 | Kokyu Alcohol Kogyo Co., Ltd. | Oily hair cosmetic |
JPWO2010116941A1 (ja) | 2009-04-10 | 2012-10-18 | 株式会社 資生堂 | 毛髪化粧料 |
WO2010116940A1 (ja) | 2009-04-10 | 2010-10-14 | 株式会社資生堂 | 毛髪化粧料 |
US20100297051A1 (en) | 2009-05-22 | 2010-11-25 | Feuillette Laetitia | Cosmetic composition comprising at least one elastomeric anionic polyurethane and at least one non-ionic thickener |
CN102652012A (zh) | 2009-12-18 | 2012-08-29 | 莱雅公司 | 处理角蛋白纤维的方法 |
WO2011116283A2 (en) | 2010-03-19 | 2011-09-22 | Kao Corporation | Hair care products containing conjugated unsaturated oils |
US9993793B2 (en) | 2010-04-28 | 2018-06-12 | The Procter & Gamble Company | Delivery particles |
WO2011156579A2 (en) * | 2010-06-10 | 2011-12-15 | Union Carbide Chemicals & Plastics Technology Llc | Personal care compositions with ethylene acrylic acid copolymer aqueous dispersions |
KR101029973B1 (ko) | 2010-08-26 | 2011-04-20 | 노현순 | 헤어 스타일링 기능이 우수한 탈모방지 조성물 및 이를 포함하는 헤어토닉 |
CN103221022A (zh) | 2010-11-18 | 2013-07-24 | 宝洁公司 | 基于n-酰基氨基酸化合物和己基癸醇的化妆品组合物 |
FR2968946B1 (fr) * | 2010-12-20 | 2013-04-19 | Oreal | Procede de coloration de fibres keratiniques a partir de derives du resorcinol, de sels de sulfate, d'agents oxydant et d'agent alcalinisant |
US20130306095A1 (en) | 2011-02-04 | 2013-11-21 | Ali N. Syed | Enhanced hair straightening system |
EP2689770A4 (en) | 2011-03-25 | 2015-05-27 | Kokyu Alcohol Kogyo Co Ltd | DAMAGED HAIR CARE AND METHOD FOR IMPROVING THE CONDITION OF DAMAGED HAIR THEREWITH |
JP5779399B2 (ja) | 2011-05-16 | 2015-09-16 | 花王株式会社 | 毛髪処理組成物 |
JP5866438B2 (ja) | 2011-06-03 | 2016-02-17 | ザ プロクター アンド ギャンブルカンパニー | 基油及びシリコーンを含む透明なヘアケア組成物 |
DE102011089357A1 (de) | 2011-12-21 | 2012-08-23 | Henkel Ag & Co. Kgaa | Haarbehandlungsmittel mit kationischen Pflegestoffen und alpha-Hydroxysäuren |
MX352276B (es) | 2011-12-22 | 2017-11-16 | Procter & Gamble | Composiciones y metodos para mejorar la apariencia del cabello envejecido. |
DE102011090030A1 (de) | 2011-12-28 | 2013-07-04 | Evonik Industries Ag | Wässrige Haar- und Hautreinigungszusammensetzungen, enthaltend Biotenside |
EP2830713B1 (en) | 2012-03-30 | 2017-10-25 | The Procter and Gamble Company | Hair conditioning composition comprising mono-alkyl amine cationic surfactant system, deposition polymer, and silicone |
EP2830714B1 (en) | 2012-03-30 | 2017-09-27 | The Procter and Gamble Company | Hair conditioning composition comprising cationic surfactant and deposition polymer |
JP2014009159A (ja) * | 2012-06-27 | 2014-01-20 | Fujifilm Corp | 染毛剤組成物 |
DE102012215799A1 (de) | 2012-09-06 | 2014-03-06 | Henkel Ag & Co. Kgaa | Haarpflegemittel mit gesteigerten Pflegeleistungen |
US20140079660A1 (en) | 2012-09-20 | 2014-03-20 | Kao Corporation | Cleansing composition for skin or hair |
JP6122620B2 (ja) | 2012-11-13 | 2017-04-26 | 株式会社ミルボン | 毛髪用処理剤 |
US20140154197A1 (en) | 2012-11-26 | 2014-06-05 | The Procter & Gamble Company | Packaged Antiperspirant Compositions |
WO2014099461A1 (en) | 2012-12-21 | 2014-06-26 | The Pisces Group Llc | Antimicrobial compositions |
CN104994832A (zh) | 2012-12-25 | 2015-10-21 | 欧莱雅公司 | 角蛋白纤维调理组合物 |
JP2016530305A (ja) | 2013-09-16 | 2016-09-29 | 花王株式会社 | 毛髪を処理するためのプロセス |
US20150313832A1 (en) | 2014-04-30 | 2015-11-05 | The Procter & Gamble Company | Method of reducing frizz and improving moisturization |
US20160015608A1 (en) | 2014-06-17 | 2016-01-21 | The Procter & Gamble Company | Composition for hair frizz reduction |
US10111815B2 (en) | 2014-06-17 | 2018-10-30 | The Procter And Gamble Company | Composition for hair frizz reduction |
MX360041B (es) | 2014-06-30 | 2018-10-18 | Procter & Gamble | Composiciones y metodos para el cuidado personal. |
US20160022558A1 (en) | 2014-07-25 | 2016-01-28 | David Ben Kunin | Hair Treatment Products and Methods for Straightening Hair |
EP4162982A3 (en) | 2014-12-05 | 2023-11-22 | The Procter & Gamble Company | Composition for hair frizz reduction |
JP6412270B2 (ja) | 2014-12-05 | 2018-10-24 | ザ プロクター アンド ギャンブル カンパニー | 縮毛を減少させるための組成物 |
JP6577033B2 (ja) | 2014-12-19 | 2019-09-18 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | 毛髪繊維特性を向上させるための組成物 |
US10632054B2 (en) | 2015-04-02 | 2020-04-28 | The Procter And Gamble Company | Method for hair frizz reduction |
US10660835B2 (en) | 2015-04-02 | 2020-05-26 | The Procter And Gamble Company | Method for hair frizz reduction |
JP6582975B2 (ja) | 2015-12-28 | 2019-10-02 | 富士通株式会社 | 半導体実装装置、半導体実装装置のヘッド及び積層チップの製造方法 |
JP6674029B2 (ja) | 2016-01-29 | 2020-04-01 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | 毛髪繊維特性を向上させるための組成物 |
US20170290755A1 (en) | 2016-04-07 | 2017-10-12 | The Procter & Gamble Company | Hair conditioning composition comprising two cationic surfactants and benefit material such as salicylic acid and 2-hexyl-1-decanol |
-
2015
- 2015-12-04 JP JP2017529734A patent/JP6412270B2/ja active Active
- 2015-12-04 EP EP15816322.0A patent/EP3226833B1/en active Active
- 2015-12-04 WO PCT/US2015/063888 patent/WO2016090206A1/en active Application Filing
- 2015-12-04 MX MX2017007279A patent/MX369683B/es active IP Right Grant
- 2015-12-04 US US14/959,234 patent/US10117819B2/en active Active
- 2015-12-04 CN CN201580066199.0A patent/CN107106437B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3541485A1 (de) * | 1985-11-23 | 1987-05-27 | Wella Ag | Verfahren zur behandlung von menschlichen haaren mit alkalischen haarbehandlungsmitteln |
JPS62132813A (ja) * | 1985-12-05 | 1987-06-16 | Sanshidou Seiyaku Kk | 毛髪処理用薬剤及び毛髪処理方法 |
JP2004210724A (ja) * | 2002-12-27 | 2004-07-29 | Lion Corp | 毛髪化粧料 |
Also Published As
Publication number | Publication date |
---|---|
WO2016090206A1 (en) | 2016-06-09 |
MX2017007279A (es) | 2017-10-16 |
CN107106437A (zh) | 2017-08-29 |
US10117819B2 (en) | 2018-11-06 |
US20160158128A1 (en) | 2016-06-09 |
MX369683B (es) | 2019-10-02 |
EP3226833B1 (en) | 2023-06-14 |
JP6412270B2 (ja) | 2018-10-24 |
JP2017536406A (ja) | 2017-12-07 |
EP3226833A1 (en) | 2017-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107106437B (zh) | 用于减少毛发卷曲的组合物 | |
CN107106457B (zh) | 用于减少毛发卷曲的组合物 | |
CN108289814B (zh) | 用于毛发卷曲减少的组合物 | |
US10561591B2 (en) | Hair care regimen using compositions comprising moisture control materials | |
EP3868444B1 (en) | Composition for hair frizz reduction | |
CN108883038B (zh) | 用于快速干燥毛发的组合物 | |
US20210145716A9 (en) | Composition for hair frizz reduction | |
EP3157499B1 (en) | Composition for hair frizz reduction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |